AnatomyDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsInformation ScienceHealth Care
Neoplasm StagingPancreatic NeoplasmsNeoplasmsEndosonographyLymphatic MetastasisSkin NeoplasmsNeoplasms, Cystic, Mucinous, and SerousTomography, X-Ray ComputedPrognosisLung NeoplasmsFluorodeoxyglucose F18Positron-Emission TomographyNeoplasms, Multiple PrimaryRadiopharmaceuticalsLiver NeoplasmsKidney NeoplasmsRetrospective StudiesLymph NodesSensitivity and SpecificityNeoplasm InvasivenessThyroid NeoplasmsNeoplasms, Second PrimaryAdenocarcinoma, MucinousAdenocarcinomaMediastinumMediastinoscopyStomach NeoplasmsGastrointestinal NeoplasmsLymphomaImmunohistochemistryTumor Markers, BiologicalParotid NeoplasmsOvarian NeoplasmsColorectal NeoplasmsDNA, NeoplasmNeoplasm MetastasisNeoplasm Recurrence, LocalRectal NeoplasmsMyeloproliferative DisordersMediastinal NeoplasmsBile Duct NeoplasmsBone NeoplasmsPredictive Value of TestsLymph Node ExcisionNose NeoplasmsBiopsy, NeedleSentinel Lymph Node BiopsyCarcinomaSurvival AnalysisCarcinoma, PapillaryEye NeoplasmsEsophageal NeoplasmsCystadenomaNeoplasms, Connective and Soft TissueAbdominal NeoplasmsNeoplasms, Plasma CellCarcinoma, Pancreatic DuctalThymus NeoplasmsMagnetic Resonance ImagingAppendiceal NeoplasmsMultimodal ImagingAdenocarcinoma, PapillarySoft Tissue NeoplasmsNeoplasms, Glandular and EpithelialCystadenoma, MucinousUterine NeoplasmsBreast NeoplasmsBiopsy, Fine-NeedleColonic NeoplasmsTreatment OutcomeBone Marrow NeoplasmsPreoperative CareEndocrine Gland NeoplasmsNeoplasm ProteinsBiopsyIntestinal NeoplasmsNeoplasms, ExperimentalMouth NeoplasmsProspective StudiesNeoplasms, Vascular TissueFollow-Up StudiesAdenomaTomography, Emission-ComputedSalivary Gland NeoplasmsSplenic NeoplasmsNeoplasms, Radiation-InducedHodgkin DiseaseReproducibility of ResultsCarcinoma, Squamous CellAntigens, NeoplasmDuodenal NeoplasmsTesticular NeoplasmsNeoplasms, Muscle TissuePleural NeoplasmsCystadenocarcinoma, MucinousGallbladder NeoplasmsUrinary Bladder NeoplasmsMelanomaHematologic NeoplasmsTongue NeoplasmsNeuroendocrine TumorsNeoplasms, Adnexal and Skin AppendageLaparotomyVascular NeoplasmsCommon Bile Duct NeoplasmsSweat Gland NeoplasmsNeoplasms, Germ Cell and EmbryonalLymphographyPalatal NeoplasmsDigestive System NeoplasmsPeritoneal NeoplasmsNeoplasms, Complex and MixedAxillaPelvic NeoplasmsHead and Neck NeoplasmsMandibular NeoplasmsCystadenocarcinomaMuscle NeoplasmsDiagnostic ImagingCombined Modality TherapyProstatic NeoplasmsThoracic NeoplasmsFalse Negative ReactionsEndometrial NeoplasmsWhole Body ImagingHeart NeoplasmsNeoplasm GradingCystadenoma, SerousMaxillary NeoplasmsPreoperative PeriodDisease ProgressionPancreatectomyDog DiseasesCarcinoma, Non-Small-Cell LungAnal Gland NeoplasmsAdenoma, OxyphilicCerebellar NeoplasmsNeoplasms, Adipose TissueLaparoscopyBronchial NeoplasmsMeningeal NeoplasmsParanasal Sinus NeoplasmsDisease-Free SurvivalTime FactorsKaplan-Meier EstimateAdrenal Cortex NeoplasmsLaryngeal NeoplasmsOrbital NeoplasmsIleal NeoplasmsSarcomaCarcinoma, HepatocellularNasopharyngeal NeoplasmsCarcinoma, Acinar CellSpinal Cord NeoplasmsVaginal NeoplasmsAdrenal Gland NeoplasmsNervous System NeoplasmsPenile NeoplasmsNeoplasm SeedingCohort StudiesGenital Neoplasms, FemaleJanus Kinase 2Neoadjuvant TherapyThymomaLiver Neoplasms, ExperimentalHemangiosarcomaAdenocarcinoma, FollicularLeiomyosarcomaMyelodysplastic-Myeloproliferative DiseasesSpinal NeoplasmsPeripheral Nervous System NeoplasmsCerebral Ventricle NeoplasmsLymphoma, T-CellBronchoscopyCarcinoma, NeuroendocrineNeck DissectionUterine Cervical NeoplasmsCarcinoma, BronchogenicCarcinosarcomaPancreaticoduodenectomyEndoscopic Ultrasound-Guided Fine Needle AspirationRisk FactorsMultivariate AnalysisRNA, NeoplasmLipomaCarcinoma, Renal CellFacial NeoplasmsFalse Positive ReactionsLymphatic DiseasesBone Marrow ExaminationFatal OutcomeGastrectomyNeoplasm TransplantationProportional Hazards ModelsRadiotherapy, AdjuvantNeoplasms by SiteIncidental FindingsCarcinoembryonic AntigenHistiocytic Disorders, MalignantImmunoenzyme TechniquesLymphoma, B-Cell
Neoplasm Staging: Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.Endosonography: Ultrasonography of internal organs using an ultrasound transducer sometimes mounted on a fiberoptic endoscope. In endosonography the transducer converts electronic signals into acoustic pulses or continuous waves and acts also as a receiver to detect reflected pulses from within the organ. An audiovisual-electronic interface converts the detected or processed echo signals, which pass through the electronics of the instrument, into a form that the technologist can evaluate. The procedure should not be confused with ENDOSCOPY which employs a special instrument called an endoscope. The "endo-" of endosonography refers to the examination of tissue within hollow organs, with reference to the usual ultrasonography procedure which is performed externally or transcutaneously.Lymphatic Metastasis: Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system.Skin Neoplasms: Tumors or cancer of the SKIN.Neoplasms, Cystic, Mucinous, and Serous: Neoplasms containing cyst-like formations or producing mucin or serum.Tomography, X-Ray Computed: Tomography using x-ray transmission and a computer algorithm to reconstruct the image.Prognosis: A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.Lung Neoplasms: Tumors or cancer of the LUNG.Fluorodeoxyglucose F18: The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162)Positron-Emission Tomography: An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower.Neoplasms, Multiple Primary: Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.Radiopharmaceuticals: Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161)Liver Neoplasms: Tumors or cancer of the LIVER.Kidney Neoplasms: Tumors or cancers of the KIDNEY.Retrospective Studies: Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.Lymph Nodes: They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system.Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)Neoplasm Invasiveness: Ability of neoplasms to infiltrate and actively destroy surrounding tissue.Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.Neoplasms, Second Primary: Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.Adenocarcinoma, Mucinous: An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)Adenocarcinoma: A malignant epithelial tumor with a glandular organization.Mediastinum: A membrane in the midline of the THORAX of mammals. It separates the lungs between the STERNUM in front and the VERTEBRAL COLUMN behind. It also surrounds the HEART, TRACHEA, ESOPHAGUS, THYMUS, and LYMPH NODES.Mediastinoscopy: Endoscopic examination, therapy or surgery of the anterior superior mediastinum of the thorax.Stomach Neoplasms: Tumors or cancer of the STOMACH.Gastrointestinal Neoplasms: Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.Immunohistochemistry: Histochemical localization of immunoreactive substances using labeled antibodies as reagents.Tumor Markers, Biological: Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.Parotid Neoplasms: Tumors or cancer of the PAROTID GLAND.Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.DNA, Neoplasm: DNA present in neoplastic tissue.Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.Neoplasm Recurrence, Local: The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.Rectal Neoplasms: Tumors or cancer of the RECTUM.Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.Mediastinal Neoplasms: Tumors or cancer of the MEDIASTINUM.Bile Duct Neoplasms: Tumors or cancer of the BILE DUCTS.Bone Neoplasms: Tumors or cancer located in bone tissue or specific BONES.Predictive Value of Tests: In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.Lymph Node Excision: Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966)Nose Neoplasms: Tumors or cancer of the NOSE.Biopsy, Needle: Removal and examination of tissue obtained through a transdermal needle inserted into the specific region, organ, or tissue being analyzed.Sentinel Lymph Node Biopsy: A diagnostic procedure used to determine whether LYMPHATIC METASTASIS has occurred. The sentinel lymph node is the first lymph node to receive drainage from a neoplasm.Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for "cancer." (From Dorland, 27th ed)Survival Analysis: A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.Carcinoma, Papillary: A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)Eye Neoplasms: Tumors or cancer of the EYE.Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.Cystadenoma: A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed)Neoplasms, Connective and Soft Tissue: Neoplasms developing from some structure of the connective and subcutaneous tissue. The concept does not refer to neoplasms located in connective or soft tissue.Abdominal NeoplasmsNeoplasms, Plasma Cell: Neoplasms associated with a proliferation of a single clone of PLASMA CELLS and characterized by the secretion of PARAPROTEINS.Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.Thymus Neoplasms: Tumors or cancer of the THYMUS GLAND.Magnetic Resonance Imaging: Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.Appendiceal Neoplasms: Tumors or cancer of the APPENDIX.Multimodal Imaging: The use of combination of imaging techniques or platforms (e.g., MRI SCAN and PET SCAN) encompassing aspects of anatomical, functional, or molecular imaging methods.Adenocarcinoma, Papillary: An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)Soft Tissue Neoplasms: Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.Neoplasms, Glandular and Epithelial: Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.Cystadenoma, Mucinous: A multilocular tumor with mucin secreting epithelium. They are most often found in the ovary, but are also found in the pancreas, appendix, and rarely, retroperitoneal and in the urinary bladder. They are considered to have low-grade malignant potential.Uterine Neoplasms: Tumors or cancer of the UTERUS.Breast Neoplasms: Tumors or cancer of the human BREAST.Biopsy, Fine-Needle: Using fine needles (finer than 22-gauge) to remove tissue or fluid specimens from the living body for examination in the pathology laboratory and for disease diagnosis.Colonic Neoplasms: Tumors or cancer of the COLON.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Bone Marrow Neoplasms: Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as MULTIPLE MYELOMA. Most bone marrow neoplasms are metastatic.Preoperative Care: Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed)Endocrine Gland Neoplasms: Tumors or cancer of the ENDOCRINE GLANDS.Neoplasm Proteins: Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.Biopsy: Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.Intestinal Neoplasms: Tumors or cancer of the INTESTINES.Neoplasms, Experimental: Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.Mouth Neoplasms: Tumors or cancer of the MOUTH.Prospective Studies: Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.Neoplasms, Vascular Tissue: Neoplasms composed of vascular tissue. This concept does not refer to neoplasms located in blood vessels.Follow-Up Studies: Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.Adenoma: A benign epithelial tumor with a glandular organization.Tomography, Emission-Computed: Tomography using radioactive emissions from injected RADIONUCLIDES and computer ALGORITHMS to reconstruct an image.Salivary Gland Neoplasms: Tumors or cancer of the SALIVARY GLANDS.Splenic Neoplasms: Tumors or cancer of the SPLEEN.Neoplasms, Radiation-Induced: Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.Reproducibility of Results: The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)Antigens, Neoplasm: Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.Duodenal Neoplasms: Tumors or cancer of the DUODENUM.Testicular Neoplasms: Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms.Neoplasms, Muscle Tissue: Neoplasms composed of muscle tissue: skeletal, cardiac, or smooth. The concept does not refer to neoplasms located in muscles.Pleural Neoplasms: Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.Cystadenocarcinoma, Mucinous: A malignant cystic or semisolid tumor most often occurring in the ovary. Rarely, one is solid. This tumor may develop from a mucinous cystadenoma, or it may be malignant at the onset. The cysts are lined with tall columnar epithelial cells; in others, the epithelium consists of many layers of cells that have lost normal structure entirely. In the more undifferentiated tumors, one may see sheets and nests of tumor cells that have very little resemblance to the parent structure. (Hughes, Obstetric-Gynecologic Terminology, 1972, p184)Gallbladder Neoplasms: Tumors or cancer of the gallbladder.Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.Tongue Neoplasms: Tumors or cancer of the TONGUE.Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.Neoplasms, Adnexal and Skin Appendage: Neoplasms composed of sebaceous or sweat gland tissue or tissue of other skin appendages. The concept does not refer to neoplasms located in the sebaceous or sweat glands or in the other skin appendages.Laparotomy: Incision into the side of the abdomen between the ribs and pelvis.Vascular Neoplasms: Neoplasms located in the vasculature system, such as ARTERIES and VEINS. They are differentiated from neoplasms of vascular tissue (NEOPLASMS, VASCULAR TISSUE), such as ANGIOFIBROMA or HEMANGIOMA.Common Bile Duct Neoplasms: Tumor or cancer of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.Sweat Gland NeoplasmsNeoplasms, Germ Cell and Embryonal: Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO, MAMMALIAN. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS.Lymphography: Radiographic study of the lymphatic system following injection of dye or contrast medium.Palatal Neoplasms: Tumors or cancer of the PALATE, including those of the hard palate, soft palate and UVULA.Digestive System Neoplasms: Tumors or cancer of the DIGESTIVE SYSTEM.Peritoneal Neoplasms: Tumors or cancer of the PERITONEUM.Neoplasms, Complex and Mixed: Neoplasms composed of more than one type of neoplastic tissue.Axilla: Area of the human body underneath the SHOULDER JOINT, also known as the armpit or underarm.Pelvic Neoplasms: Tumors or cancer of the pelvic region.Head and Neck Neoplasms: Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)Mandibular Neoplasms: Tumors or cancer of the MANDIBLE.Cystadenocarcinoma: A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)Muscle Neoplasms: Tumors or cancer located in muscle tissue or specific muscles. They are differentiated from NEOPLASMS, MUSCLE TISSUE which are neoplasms composed of skeletal, cardiac, or smooth muscle tissue, such as MYOSARCOMA or LEIOMYOMA.Diagnostic Imaging: Any visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy.Combined Modality Therapy: The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.Prostatic Neoplasms: Tumors or cancer of the PROSTATE.Thoracic NeoplasmsFalse Negative Reactions: Negative test results in subjects who possess the attribute for which the test is conducted. The labeling of diseased persons as healthy when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed)Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.Whole Body Imaging: The creation of a visual display of the inside of the entire body of a human or animal for the purposes of diagnostic evaluation. This is most commonly achieved by using MAGNETIC RESONANCE IMAGING; or POSITRON EMISSION TOMOGRAPHY.Heart Neoplasms: Tumors in any part of the heart. They include primary cardiac tumors and metastatic tumors to the heart. Their interference with normal cardiac functions can cause a wide variety of symptoms including HEART FAILURE; CARDIAC ARRHYTHMIAS; or EMBOLISM.Neoplasm Grading: Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.Cystadenoma, Serous: A cystic tumor of the ovary, containing thin, clear, yellow serous fluid and varying amounts of solid tissue, with a malignant potential several times greater than that of mucinous cystadenoma (CYSTADENOMA, MUCINOUS). It can be unilocular, parvilocular, or multilocular. It is often bilateral and papillary. The cysts may vary greatly in size. (Dorland, 27th ed; from Hughes, Obstetric-Gynecologic Terminology, 1972)Maxillary Neoplasms: Cancer or tumors of the MAXILLA or upper jaw.Preoperative Period: The period before a surgical operation.Disease Progression: The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.Pancreatectomy: Surgical removal of the pancreas. (Dorland, 28th ed)Dog Diseases: Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used.Carcinoma, Non-Small-Cell Lung: A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.Anal Gland Neoplasms: Tumors or cancer of the anal gland.Adenoma, Oxyphilic: A usually benign glandular tumor composed of oxyphil cells, large cells with small irregular nuclei and dense acidophilic granules due to the presence of abundant MITOCHONDRIA. Oxyphil cells, also known as oncocytes, are found in oncocytomas of the kidney, salivary glands, and endocrine glands. In the thyroid gland, oxyphil cells are known as Hurthle cells and Askanazy cells.Cerebellar Neoplasms: Primary or metastatic neoplasms of the CEREBELLUM. Tumors in this location frequently present with ATAXIA or signs of INTRACRANIAL HYPERTENSION due to obstruction of the fourth ventricle. Common primary cerebellar tumors include fibrillary ASTROCYTOMA and cerebellar HEMANGIOBLASTOMA. The cerebellum is a relatively common site for tumor metastases from the lung, breast, and other distant organs. (From Okazaki & Scheithauer, Atlas of Neuropathology, 1988, p86 and p141)Neoplasms, Adipose Tissue: Neoplasms composed of fatty tissue or connective tissue made up of fat cells in a meshwork of areolar tissue. The concept does not refer to neoplasms located in adipose tissue.Laparoscopy: A procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy.Bronchial Neoplasms: Tumors or cancer of the BRONCHI.Meningeal Neoplasms: Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.Paranasal Sinus Neoplasms: Tumors or cancer of the PARANASAL SINUSES.Disease-Free Survival: Period after successful treatment in which there is no appearance of the symptoms or effects of the disease.Time Factors: Elements of limited time intervals, contributing to particular results or situations.Kaplan-Meier Estimate: A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)Adrenal Cortex Neoplasms: Tumors or cancers of the ADRENAL CORTEX.Laryngeal Neoplasms: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.Orbital Neoplasms: Neoplasms of the bony orbit and contents except the eyeball.Ileal Neoplasms: Tumors or cancer in the ILEUM region of the small intestine (INTESTINE, SMALL).Sarcoma: A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.Carcinoma, Acinar Cell: A malignant tumor arising from secreting cells of a racemose gland, particularly the salivary glands. Racemose (Latin racemosus, full of clusters) refers, as does acinar (Latin acinus, grape), to small saclike dilatations in various glands. Acinar cell carcinomas are usually well differentiated and account for about 13% of the cancers arising in the parotid gland. Lymph node metastasis occurs in about 16% of cases. Local recurrences and distant metastases many years after treatment are common. This tumor appears in all age groups and is most common in women. (Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1240; from DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575)Spinal Cord Neoplasms: Benign and malignant neoplasms which occur within the substance of the spinal cord (intramedullary neoplasms) or in the space between the dura and spinal cord (intradural extramedullary neoplasms). The majority of intramedullary spinal tumors are primary CNS neoplasms including ASTROCYTOMA; EPENDYMOMA; and LIPOMA. Intramedullary neoplasms are often associated with SYRINGOMYELIA. The most frequent histologic types of intradural-extramedullary tumors are MENINGIOMA and NEUROFIBROMA.Vaginal Neoplasms: Tumors or cancer of the VAGINA.Adrenal Gland Neoplasms: Tumors or cancer of the ADRENAL GLANDS.Nervous System Neoplasms: Benign and malignant neoplastic processes arising from or involving components of the central, peripheral, and autonomic nervous systems, cranial nerves, and meninges. Included in this category are primary and metastatic nervous system neoplasms.Penile Neoplasms: Cancers or tumors of the PENIS or of its component tissues.Neoplasm Seeding: The local implantation of tumor cells by contamination of instruments and surgical equipment during and after surgical resection, resulting in local growth of the cells and tumor formation.Cohort Studies: Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.Genital Neoplasms, Female: Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).Janus Kinase 2: A Janus kinase subtype that is involved in signaling from GROWTH HORMONE RECEPTORS; PROLACTIN RECEPTORS; and a variety of CYTOKINE RECEPTORS such as ERYTHROPOIETIN RECEPTORS and INTERLEUKIN RECEPTORS. Dysregulation of Janus kinase 2 due to GENETIC TRANSLOCATIONS have been associated with a variety of MYELOPROLIFERATIVE DISORDERS.Neoadjuvant Therapy: Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.Thymoma: A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed)Liver Neoplasms, Experimental: Experimentally induced tumors of the LIVER.Hemangiosarcoma: A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)Adenocarcinoma, Follicular: An adenocarcinoma of the thyroid gland, in which the cells are arranged in the form of follicles. (From Dorland, 27th ed)Leiomyosarcoma: A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865)Myelodysplastic-Myeloproliferative Diseases: Clonal myeloid disorders that possess both dysplastic and proliferative features but are not properly classified as either MYELODYSPLASTIC SYNDROMES or MYELOPROLIFERATIVE DISORDERS.Spinal NeoplasmsPeripheral Nervous System Neoplasms: Neoplasms which arise from peripheral nerve tissue. This includes NEUROFIBROMAS; SCHWANNOMAS; GRANULAR CELL TUMORS; and malignant peripheral NERVE SHEATH NEOPLASMS. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp1750-1)Cerebral Ventricle Neoplasms: Neoplasms located in the brain ventricles, including the two lateral, the third, and the fourth ventricle. Ventricular tumors may be primary (e.g., CHOROID PLEXUS NEOPLASMS and GLIOMA, SUBEPENDYMAL), metastasize from distant organs, or occur as extensions of locally invasive tumors from adjacent brain structures.Lymphoma, T-Cell: A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.Bronchoscopy: Endoscopic examination, therapy or surgery of the bronchi.Carcinoma, Neuroendocrine: A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round "blue cells", granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small ("oat") cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992)Neck Dissection: Dissection in the neck to remove all disease tissues including cervical LYMPH NODES and to leave an adequate margin of normal tissue. This type of surgery is usually used in tumors or cervical metastases in the head and neck. The prototype of neck dissection is the radical neck dissection described by Crile in 1906.Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.Carcinoma, Bronchogenic: Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.Carcinosarcoma: A malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. (Stedman, 25th ed)Pancreaticoduodenectomy: The excision of the head of the pancreas and the encircling loop of the duodenum to which it is connected.Endoscopic Ultrasound-Guided Fine Needle Aspiration: Conducting a fine needle biopsy with the aid of ENDOSCOPIC ULTRASONOGRAPHY.Risk Factors: An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.Multivariate Analysis: A set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.RNA, Neoplasm: RNA present in neoplastic tissue.Lipoma: A benign tumor composed of fat cells (ADIPOCYTES). It can be surrounded by a thin layer of connective tissue (encapsulated), or diffuse without the capsule.Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.Facial NeoplasmsFalse Positive Reactions: Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed)Lymphatic Diseases: Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS.Bone Marrow Examination: Removal of bone marrow and evaluation of its histologic picture.Fatal Outcome: Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.Gastrectomy: Excision of the whole (total gastrectomy) or part (subtotal gastrectomy, partial gastrectomy, gastric resection) of the stomach. (Dorland, 28th ed)Neoplasm Transplantation: Experimental transplantation of neoplasms in laboratory animals for research purposes.Proportional Hazards Models: Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.Radiotherapy, Adjuvant: Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.Neoplasms by Site: A collective term for precoordinated organ/neoplasm headings locating neoplasms by organ, as BRAIN NEOPLASMS; DUODENAL NEOPLASMS; LIVER NEOPLASMS; etc.Incidental Findings: Unanticipated information discovered in the course of testing or medical care. Used in discussions of information that may have social or psychological consequences, such as when it is learned that a child's biological father is someone other than the putative father, or that a person tested for one disease or disorder has, or is at risk for, something else.Carcinoembryonic Antigen: A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment.Histiocytic Disorders, Malignant: Distinctive neoplastic disorders of histiocytes. Included are malignant neoplasms of MACROPHAGES and DENDRITIC CELLS.Immunoenzyme Techniques: Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.Lymphoma, B-Cell: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.

Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma. (1/18612)

The association of p53 abnormalities with the prognosis of patients with non-small cell lung carcinoma (NSCLC) has been extensively investigated to date, however, this association is still controversial. Therefore, we investigated the prognostic significance of p53 mutations through exons 2 to 11 and p53 protein expression in 103 cases of stage I NSCLC. p53 mutations were detected in 49 of 103 (48%) tumors. Two separate mutations were detected in four tumors giving a total of 53 unique mutations in 49 tumors. Ten (19%) of mutations occurred outside exons 5-8. Positive immunohistochemical staining of p53 protein was detected in 41 of 103 (40%) tumors. The concordance rate between mutations and protein overexpression was only 69%. p53 mutations, but not expression, were significantly associated with a shortened survival of patients (P<0.001). Furthermore, we investigated the correlation between the types of p53 mutations and prognosis. p53 missense mutations rather than null mutations were associated with poor prognosis (P < 0.001 in missense mutations and P=0.243 in null mutations). These results indicated that p53 mutations, in particular missense mutations, rather than p53 expression could be a useful molecular marker for the prognosis of patients with surgically resected stage I NSCLC.  (+info)

Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer. (2/18612)

OBJECTIVE: To determine the sensitivity, specificity, and accuracy of positron emission tomography with 2-fluorine-18-fluorodeoxyglucose (PET-FDG) in the preoperative staging (N and M staging) of patients with lung cancer. The authors wanted to compare the efficacy of PET scanning with currently used computed tomography (CT) scanning. MATERIALS AND METHODS: Results of whole-body PET-FDG imaging and CT scans were compared with histologic findings for the presence or absence of lymph node disease or metastatic sites. Sampling of mediastinal lymph nodes was performed using mediastinoscopy or thoracotomy. RESULTS: PET-FDG imaging was significantly more sensitive, specific, and accurate for detecting N disease than CT. PET changed N staging in 35% and M staging in 11% of patients. CT scans helped in accurate anatomic localization of 6/57 PET lymph node abnormalities. CONCLUSION: PET-FDG is a reliable method for preoperative staging of patients with lung cancer and would help to optimize management of these patients. Accurate lymph node staging of lung cancer may be ideally performed by simultaneous review of PET and CT scans.  (+info)

A blind comparison of the effectiveness of endoscopic ultrasonography and endoscopy in staging early gastric cancer. (3/18612)

BACKGROUND/AIMS: Endoscopic ultrasonography is expected to be useful for invasion depth staging of early gastric cancer. A prospective blind study of the staging characteristics of endoscopy and endoscopic ultrasonography for early gastric cancer was performed. METHODS: Findings of endoscopy and endoscopic ultrasonography using a 20 MHz thin ultrasound probe were independently reviewed and the results of 52 early gastric cancer lesions analysed. RESULTS: The overall accuracy rates in invasion depth staging of early gastric cancer were 63% for endoscopy and 71% for endoscopic ultrasonography. No statistically significant differences were observed in overall accuracy. Endoscopic ultrasonography tended to overstage, and lesions that were classified as mucosal cancer by endoscopic ultrasonography were very likely (95%) to be limited to the mucosa on histological examination. All 16 lesions staged as mucosal cancer independently but coincidentally by both methods were histologically limited to the mucosa. CONCLUSIONS: Endoscopic ultrasonography is expected to compensate for the understaging of lesions with submucosal invasion that are endoscopically staged as mucosal cancer.  (+info)

Evidence of improving survival of patients with rectal cancer in france: a population based study. (4/18612)

BACKGROUND: Over the past 20 years there have been many changes in the management of rectal cancer. Their impact on the overall population is not well known. AIMS: To determine trends in management and prognosis of rectal cancer in two French regions. SUBJECTS: 1978 patients with a rectal carcinoma diagnosed between 1978 and 1993. METHODS: Time trends in treatment, stage at diagnosis, operative mortality, and survival were studied on a four year basis. A non-conditional logistic regression was performed to obtain an odds ratio for each period adjusted for the other variables. To estimate the independent effect of the period a multivariate relative survival analysis was performed. RESULTS: Over the 16 year period resection rates increased from 66.0% to 80.1%; the increase was particularly noticeable for sphincter saving procedures (+30.6% per four years, p=0.03). The percentage of patients receiving adjuvant radiotherapy increased from 24.0% to 40.0% (p=0.02). The proportion of patients with Dukes' type A cancer increased from 17. 7% to 30.6% with a corresponding decrease in those with more advanced disease. Operative mortality decreased by 31.1% per four years (p=0.03). All these improvements have resulted in a dramatic increase in relative survival (from 35.4% for the 1978-1981 period to 57.0% for the 1985-1989 period). CONCLUSIONS: Substantial advances in the management of rectal cancer have been achieved, but there is evidence that further improvements can be made in order to increase survival.  (+info)

Immunocytochemically detected free peritoneal tumour cells (FPTC) are a strong prognostic factor in gastric carcinoma. (5/18612)

We prospectively investigated the prognostic significance of free peritoneal tumour cells (FPTC) in a series of 118 patients with completely resected gastric carcinoma. Immunocytochemistry with the monoclonal antibody Ber-Ep4 was performed on cytospins from intraoperative peritoneal lavage specimens. Twenty-three patients (20%) had FPTC which was significantly correlated with pT and pN categories, stage, tumour size, lymphatic invasion, Lauren and WHO classifications and perigastric adipose tissue metastases. The median survival time for all FPTC positive compared with negative patients was significantly shorter (11 compared with >72 months), with estimated 5-year survival rates of 8% vs. 60%. None of the patients with FPTC had an early gastric cancer. In advanced tumour subgroups without and with serosal invasion (n = 59 and 35), there were 19% and 34% with FPTC. Multivariate survival analysis showed nodal status, FPTC, mesenteric lymphangiosis, and lymph node metastasis to the compartment III to be independent prognostic factors with relative risks of 6.6, 4.5, 2.9 and 2.2 respectively. Recurrent disease occurred in 91% of FPTC-positive and in 38% of FPTC-negative patients. FPTC had a positive predictive value of 91% and a specificity of 97% for tumour recurrence. FPTC is a strong negative, independent prognostic indicator for survival in gastric carcinoma.  (+info)

Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. (6/18612)

Chronic lymphocytic leukemia (CLL) shows a remarkably heterogeneous clinical outcome; survival ranges from several months in advanced stages to more than 10 years in early stages. The Binet and Rai staging systems distinguish three major prognostic subgroups, but do not accurately predict the individual risk of disease progression in early CLL (Binet stage A or Rai stage 0 to II). Because most newly diagnosed CLL patients present with early disease, it seems desirable to search for additional prognostic factors to identify early CLL patients at high risk of rapid progression. It has been shown that elevated serum thymidine kinase (s-TK) levels predict disease progression in CLL. Therefore, this study aimed to assess the prognostic value of s-TK in 122 previously untreated patients with Binet stage A CLL (mean age +/- SD, 58.7 +/- 8.5 years). In univariate analyses, 18 of the 22 parameters investigated predicted progression-free survival (PFS). In a stepwise multiple regression analysis, only three parameters provided independent prognostic information on PFS: s-TK greater than 7.1 U/L; presence of lymphadenopathy; and white blood cell (WBC) count greater than 75, 000/microL. When added to the classification of smoldering versus nonsmoldering CLL, s-TK levels separated two groups within the group of nonsmoldering stage A patients: patients with s-TK values greater than 7.1 U/L had a median PFS of 8 months, whereas patients with s-TK values +info)

Detection of occult lymph node metastases in esophageal cancer by minimally invasive staging combined with molecular diagnostic techniques. (7/18612)

BACKGROUND AND OBJECTIVES: Lymph node metastases are the most important prognostic factor in patients with esophageal cancer. Histologic examination misses micrometastases in up to 20% of lymph nodes evaluated. In addition, non-invasive imaging modalities are not sensitive enough to detect small lymph nodes metastases. The objective of this study was to investigate the use of reverse transcriptase-polymerase chain reaction (RT-PCR) of messenger RNA (mRNA) for carcinoembryonic antigen (CEA) to increase the detection of micrometastases in lymph nodes from patients with esophageal cancer. METHODS: RT-PCR of CEA mRNA was performed in lymph nodes from patients with malignant and benign esophageal disease. Each specimen was examined histopathologically and by RT-PCR and the results were compared. RESULTS: Metastases were present in 29 of 60 (48%) lymph nodes sample by minimally invasive staging from 13 patients with esophageal cancer when examined histopathologically. RT-PCR identified nodal metastases in 46 of these 60 (77%) samples. RT-PCR detected CEA mRNA in all 29 histologically positive samples and in 17 histologically negative lymph nodes. All lymph nodes from patients with benign disease (n = 15) were negative both histopathologically and by RT-PCR. The stage of two patients was reclassified based on the RT-PCR results, which identified lymph node spread undetected histopathologically. Both of these patients developed recurrent disease after resection of the primary tumor. CONCLUSIONS: RT-PCR is more sensitive than histologic examination in the detection of lymph node metastases in esophageal cancer and can lead to diagnosis of a more advanced stage in some patients. The combination of minimally invasive surgical techniques in combination with new molecular diagnostic techniques may improve our ability to stage cancer patients.  (+info)

Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. (8/18612)

BACKGROUND: Conventional cytologic analysis of sputum is an insensitive test for the diagnosis of non-small-cell lung cancer (NSCLC). We have recently demonstrated that polymerase chain reaction (PCR)-based molecular methods are more sensitive than cytologic analysis in diagnosing bladder cancer. In this study, we examined whether molecular assays could identify cancer cells in bronchoalveolar lavage (BAL) fluid. METHODS: Tumor-specific oncogene mutations, CpG-island methylation status, and microsatellite alterations in the DNA of cells in BAL fluid from 50 consecutive patients with resectable (stages I through IIIa) NSCLC were assessed by use of four PCR-based techniques. RESULTS: Of 50 tumors, 28 contained a p53 mutation, and the identical mutation was detected with a plaque hybridization assay in the BAL fluid of 39% (11 of 28) of the corresponding patients. Eight of 19 adenocarcinomas contained a K-ras mutation, and the identical mutation was detected with a mutation ligation assay in the BAL fluid of 50% (four of eight) of the corresponding patients. The p16 gene was methylated in 19 of 50 tumors, and methylated p16 alleles were detected in the BAL fluid of 63% (12 of 19) of the corresponding patients. Microsatellite instability in at least one marker was detected with a panel of 15 markers frequently altered in NSCLC in 23 of 50 tumors; the identical alteration was detected in the BAL fluid of 14% (three of 22) of the corresponding patients. When all four techniques were used, mutations or microsatellite instability was detected in the paired BAL fluid of 23 (53%) of the 43 patients with tumors carrying a genetic alteration. CONCLUSION: Although still limited by sensitivity, molecular diagnostic strategies can detect the presence of neoplastic cells in the proximal airway of patients with surgically resectable NSCLC.  (+info)

1076 Independent validation of the 2010 TNM staging system for renal cell carcinoma : does it improves predictive accuracy in...1076 Independent validation of the 2010 TNM staging system for renal cell carcinoma : does it improves predictive accuracy in...
INTRODUCTION & OBJECTIVES: The 2010 TNM staging system provided several changes in pT classification: pT2 stage is splitted in pT2a (,= 10 cm) and pT2b (,10 cm); patients with tumor thrombus invading the renal vein are classified as pT3a; infiltration of the wall of the vena cava as pT3c; direct invasion of the adrenal gland is inserted in pT4 stage. Moreover all nodal involvement is classified as pN1. We aimed to analyze wether the new TNM staging system is more accurate than the 2002 TNM classification in predicting the risk of cancer-specific mortality (CSM). MATERIAL & METHODS: We retrospectively analyzed data of 14040 consecutive patients who underwent radical nephrectomy or nephron-sparing surgery for RCC, between 1987 and 2008. The Kaplan-Meier method and univariable and multivariable Cox regression analyses were used to determine the effect of the 2002 TNM and of the new TNM staging system on CSM. Finally, we compared the accuracy of the 2002 TNM and of the 2010 TNM staging system ...
Impact of the 7th Edition AJCC Staging Classification on the NCCN Clinical Practice Guidelines in Oncology for Gastric and...Impact of the 7th Edition AJCC Staging Classification on the NCCN Clinical Practice Guidelines in Oncology for Gastric and...
Patients with potentially resectable gastric cancer should undergo multidisciplinary evaluation. The new staging system and treatment guidelines will improve outcomes for patients with esophageal carcinoma. The 7th edition of the AJCC Cancer Staging Manual improves the T designations for T1 and T4 tumors, improves the prognostic stratification of the N status by incorporating nodal involvement quantitatively, and has added clearer definitions for M1 disease to optimize treatment options.. Despite the improvements made in the most recent classification, several controversial issues still impact treatment guidelines. The most significant one relates to GEJ tumors.. GEJ Issues: Another important change in the recently adopted 7th AJCC/Union Internationale Contre le Cancer (UICC) staging system for esophageal and gastric cancer is a clearer definition of GEJ tumors. This presents a frequent controversy for surgical and medical oncologists, and similar patients with involvement just above or below ...
TNM Staging System - AMA Manual of StyleTNM Staging System - AMA Manual of Style
The TNM staging system is an internationally standardized system for the staging of cancer and is in its seventh decade of continuing formulation. The TNM classification is put forth by the American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (UICC; http://www.uicc.org). The AJCCs Cancer Staging Manual and the UICCs TNM Classification of Malignant Tumours present the stages of cancer as defined by TNM classifications. The TNM definitions and stage groupings are based on prognostic outcome. Information about TNM may be accessed at the UICC website, http://www.uicc.org/index.php?id=508. The TNM symbols follow. ▪ T: tumor (indicates size, extent,
TNM Staging System - AMA Manual of StyleTNM Staging System - AMA Manual of Style
The TNM staging system is an internationally standardized system for the staging of cancer and is in its seventh decade of continuing formulation. The TNM classification is put forth by the American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (UICC; http://www.uicc.org). The AJCCs Cancer Staging Manual and the UICCs TNM Classification of Malignant Tumours present the stages of cancer as defined by TNM classifications. The TNM definitions and stage groupings are based on prognostic outcome. Information about TNM may be accessed at the UICC website, http://www.uicc.org/index.php?id=508. The TNM symbols follow. ▪ T: tumor (indicates size, extent,
Do Largest Basal Tumor Diameter and the American Joint Committee on Cancers Cancer Staging Influence Prognostication by Gene...Do Largest Basal Tumor Diameter and the American Joint Committee on Cancer's Cancer Staging Influence Prognostication by Gene...
Do Largest Basal Tumor Diameter and the American Joint Committee on Cancers Cancer Staging Influence Prognostication by Gene Expression Profiling in Choroidal Melanoma.
A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer - Full Text View -...A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer - Full Text View -...
Eligibility Criteria. Patients must have histologically or cytologically confirmed Squamous Cell Cancer of the Head and Neck either (a) metastatic (i.e. American Joint Committee on Cancer Staging System, 6th edition, stage IVC) or (b) recurrent, judged incurable by surgery or radiation.. Patients must have measurable disease, defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded) as ,20 mm with conventional techniques or as ,10 mm with CT scan). RECIST criteria will be used (see section 9).. Therapeutic history in conformance with the following:. No more than one prior adjuvant/neoadjuvant chemotherapy and/or concomitant chemoradiotherapy regimen that may have included biologic/targeted agent.. No more than one prior regimen (chemotherapy or biologic/targeted) for recurrent/metastatic disease. ECOG performance status of 0-2 (Karnofsky , 60%; see Appendix A).. Patients must have normal organ and marrow function as defined ...
The American Joint Committee on Cancer: updating the strategies in cancer staging. - Semantic ScholarThe American Joint Committee on Cancer: updating the strategies in cancer staging. - Semantic Scholar
Semantic Scholar extracted view of The American Joint Committee on Cancer: updating the strategies in cancer staging. by Frederick L Greene
New Staging System IDs cSCC Risk in Transplant Patients - MPRNew Staging System IDs cSCC Risk in Transplant Patients - MPR
The newly updated seventh edition American Joint Committee on Cancer (AJCC) staging system accurately predicts the risk of recurrence of cutaneous squamous cell carcinoma (cSCC) in high-risk heart and lung transplant recipients.
Comparison of 6th and 7th AJCC TNM Staging Classification for Carcinoma of the Stomach in China | Springer for Research &...Comparison of 6th and 7th AJCC TNM Staging Classification for Carcinoma of the Stomach in China | Springer for Research &...
Background The 7th edition of American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging system was put into use recently. The study aimed to evaluate its predictive ability on...
Lung cancer (staging - IASLC 8th edition) | Radiology Reference Article | Radiopaedia.orgLung cancer (staging - IASLC 8th edition) | Radiology Reference Article | Radiopaedia.org
The IASLC (International Association for the Study of Lung Cancer) 8th edition lung cancer staging system was introduced in 2016 and supersedes the IASLC 7th edition. Standard-of-care lung cancer staging ideally should be performed in a multidi...
What is Tumor Staging and Why is it Important?What is Tumor Staging and Why is it Important?
To determine the stage of a tumor, a healthcare provider may order lab tests, X-rays, or other procedures depending on each individual case.. Cancer staging can be categorized into clinical stage and pathologic stages. The clinical staging is performed before the tumor is removed. The healthcare professional may use a variety of tools, such as blood test, imaging studies (such as Ultrasound scans, Computed Tomography or CT scans, Magnetic Resonance Imaging or MRI scans, Positron Emission Tomography or PET scans, and Bone scans) and physical examination. The pathologic staging is performed when the pathologist examines the tumor tissue after the surgery.. In general, the pathologic stage is more accurate than clinical stage. However, since the two staging systems use different methods, they may differ frequently. In many cases, the information derived from the two staging methods complement each other. Sometimes, treatments such as radiation therapy or chemotherapy are initiated before surgery. ...
Variation between multidisciplinary tumor boards in clinical staging and treatment recommendations for patients with locally...Variation between multidisciplinary tumor boards in clinical staging and treatment recommendations for patients with locally...
Accurate diagnosis and staging is crucial to ensure uniform allocation to the optimal treatment modalities for non-small cell lung cancer (NSCLC), but may differ between multidisciplinary tumor boards (MDT). Discordance between clinical and pathological TNM-stage is particularly important for patients with locally advanced NSCLC (stage IIIA) because it may influence their chance of allocation to curative intent treatment. We therefore aimed to study agreement on staging and treatment to gain insight in MDT decision making.What is the level of agreement on clinical staging and treatment recommendations between MDTs in stage IIIA NSCLC patients?Eleven MDTs each evaluated the same 10 pathological stage IIIA NSCLC patients in their weekly meeting (n=110). Cases were purposively selected for their challenging nature. All MDTs received exactly the same clinical information and images per patient. We tested agreement in cT-stage, cN-stage, cM-stage (TNM 8th edition) and treatment proposal between ...
Prognostic and predictive factors in colorectal cancer | Postgraduate Medical JournalPrognostic and predictive factors in colorectal cancer | Postgraduate Medical Journal
Prognostication of newly diagnosed colorectal cancer (CRC) predominantly relies on stage as defined by the UICC-TNM and American Joint Committee on Cancer classifications. Tumour extent, lymph node status, tumour grade and the assessment of lymphatic and venous invasion are still the most important morphological prognostic factors. Evidence suggests that tumour budding and tumour border configuration are important, additional histological parameters but are not regarded as essential in prognosis. Although several molecular features, such as LOH18q and TP53 mutation analysis, have shown promising results in terms of their prognostic value, the American Society of Clinical Oncology Tumor Markers Expert Panel does not currently recommend their use in routine practice. cDNA-microarray, PCR and fluorescence in situ hybridisation are now frequently used to identity potential prognostic indicators in CRC, but the applicability of these methods in routine use is likely to have limited impact. Reliable ...
Imaging Tests for the Staging of Colorectal Cancer | Effective Health Care ProgramImaging Tests for the Staging of Colorectal Cancer | Effective Health Care Program
For preoperative rectal cancer T (tumor) staging, ERUS is more accurate than CT; ERUS is less likely than CT to incorrectly stage (odds ratio [OR] = 0.36; 95% confidence interval [CI], 0.24 to 0.54), less likely to understage (OR = 0.63; 95% CI, 0.44 to 0.89), and less likely to overstage (OR = 0.47; 95% CI, 0.28 to 0.80), supported by evidence of low strength. For preoperative rectal cancer T staging, MRI and ERUS were similar in accuracy, supported by evidence of low strength. There was no statistical difference in accuracy between MRI and CT, but there were few patients in the available studies. For preoperative rectal cancer N (lymph node) staging, CT, MRI, and ERUS were similar in overall accuracy, but all three modalities had limited sensitivity. MRI was less likely to overstage preoperative rectal cancer N stage than CT (OR = 0.498; 95% CI, 0.308 to 0.806), supported by evidence of low strength. We identified only one study of preoperative T and N staging of colorectal cancer using CT ...
Gastric carcinoma: imaging diagnosis, staging and assessment of treatment response | ScholarBank@NUSGastric carcinoma: imaging diagnosis, staging and assessment of treatment response | [email protected]
Gastric carcinoma (GC) is one of the most common causes of cancer-related death worldwide. Surgical resection is the only cure available and is dependent on the GC stage at presentation, which incorporates depth of tumor invasion, extent of lymph node and distant metastases. Accurate preoperative staging is therefore essential for optimal surgical management with consideration of preoperative and/or postoperative chemotherapy. Multidetector computed tomography (MDCT) with its ability to assess tumor depth, nodal disease and metastases is the preferred technique for staging GC. Endoscopic ultrasonography is more accurate for assessing the depth of wall invasion in early cancer, but is limited in the assessment of advanced local or stenotic cancer and detection of distant metastases. Magnetic resonance imaging (MRI), although useful for staging, is not proven to be effective. Positron emission tomography (PET) is most useful for detecting and characterizing distant metastases. Both MDCT and PET ...
Welcome to CDC stacksWelcome to CDC stacks
BACKGROUND The American Joint Committee on Cancers (AJCC) 7th edition cancer staging manual reflects recent changes in cancer care practices. This report assesses changes from the AJCC 6th to the AJCC 7th edition stage distributions and the quality of site-specific factors (SSFs). METHODS Incidence data for renal parenchyma and pelvis and ureter cancers from 18 Surveillance, Epidemiology, and End Results (SEER) registries were examined, including staging trends during 2004-2010, stage distribution changes between the AJCC 6th and 7th editions, and SSF completeness for cases diagnosed in 2010. RESULTS From 2004 to 2010, the percentage of stage I renal parenchyma cancers increased from 50% to 58%, whereas stage IV and unknown stage cases decreased (18% to 15%, and 10% to 6%, respectively). During this period, the percentage of stage 0a renal pelvis and ureter cancers increased from 21% to 25%, and stage IV and unknown stage tumors decreased (20% to 18%, and 7% to 5%, respectively). Stage ...
Predictors of pathologic complete response after preoperative concurrent chemoradiotherapy of rectal cancer: a single center...Predictors of pathologic complete response after preoperative concurrent chemoradiotherapy of rectal cancer: a single center...
From a clinical perspective, although T2 stage cancer is not an indication for CCRT in the National Comprehensive Cancer Networkguidelines [2-6], some patients with T2 stage cancers undergo CCRT. CCRT was associated with a high pCR rate in some studies, including in our study. Therefore, CCRT may be suitable for selected patients who require analsparing procedures. A major factor in selecting CCRT for T2 stage cancer is precise T staging using appropriate imaging modalities, and this attempts to predict pCR. A long interval between finishing CCRT and surgery was a significant predictive factor in the multivariate analysis in our study. Thus, the timing of surgery is important. Some studies reported the interval between CCRT and surgery [25,26], in which the interval ranged from 4 to 8 weeks. Based on the findings of these studies, all patients could undergo complete resection without an increased rate of postoperative complications. According to these results, an interval of 4-8 weeks from ...
PROGNOSTIC VALUE OF A CARDIAC DAMAGE STAGING CLASSIFICATION IN.... CCC ePoster Library. Bernard J. Oct 26 2019; 280535PROGNOSTIC VALUE OF A CARDIAC DAMAGE STAGING CLASSIFICATION IN.... CCC ePoster Library. Bernard J. Oct 26 2019; 280535
Instantly find & access educational materials and complete eLearning activities at your leisure. Native iPad/iPhone/Android Apps are available for the convenience of on-the-go users.
CorpusCarcinoma - Schema IndexCorpusCarcinoma - Schema Index
Note 1: AJCC 7th Edition TNM staging reflects the new staging adopted by the International Federation of Gynecology and Obstetrics (FIGO) and utilizes three new staging schemas for cancer of the Corpus Uteri based on histology. This is a change from the AJCC 6th Edition TNM staging. The three new schemas are ...
CDC - Cancer - NPCR - TNM 7th Edition Staging APICDC - Cancer - NPCR - TNM 7th Edition Staging API
CDC has created software in the form of a dynamic link library (DLL) to help cancer registries collect data on stage of disease for cancers according to the TNM system of the American Joint Committee on Cancer (AJCC).
T staging using MSCT and EUS.A. MSCT-T1 tumor: Transver | Open-iT staging using MSCT and EUS.A. MSCT-T1 tumor: Transver | Open-i
T staging using MSCT and EUS.A. MSCT-T1 tumor: Transverse CT image shows an elevated lesion (arrow) of the gastric mucosa of the lesser curvature with a clear f
Surgical Treatment for Lung Cancer | Columbia University Department of SurgerySurgical Treatment for Lung Cancer | Columbia University Department of Surgery
Treatment of lung cancer is stage dependent. For complete information on cancer staging, go to the American Joint Committee on Cancer.
Characteristics of patients with missing information on stage: a population-based study of patients diagnosed with colon, lung...Characteristics of patients with missing information on stage: a population-based study of patients diagnosed with colon, lung...
Stage is a key predictor of cancer survival. Complete cancer staging is vital for understanding outcomes at population level and monitoring the efficacy of early diagnosis initiatives. Cancer registries usually collect details of the disease extent but staging information may be missing because a stage was never assigned to a patient or because it was not included in cancer registration records. Missing stage information introduce methodological difficulties for analysis and interpretation of results. We describe the associations between missing stage and socio-demographic and clinical characteristics of patients diagnosed with colon, lung or breast cancer in England in 2013. We assess how these associations change when completeness is high, and administrative issues are assumed to be minimal. We estimate the amount of avoidable missing stage data if high levels of completeness reached by some Clinical Commissioning Groups (CCGs), were achieved nationally. Individual cancer records were retrieved from
SEVEN THAT SPELLS You Must Do This on Stage Vol. 1 reviewsSEVEN THAT SPELLS You Must Do This on Stage Vol. 1 reviews
You Must Do This on Stage Vol. 1 is a music live recording by SEVEN THAT SPELLS (Psychedelic/Space Rock/Progressive Rock) released in 2009 on cd, lp / vinyl and/or cassette. This page includes You Must Do This on Stage Vol. 1s : cover picture, songs / tracks list, members/musicians and line-up, different releases details, free MP3 download (stream), buy online links: ebay and amazon, ratings and detailled reviews by our experts, collaborators and members.
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women With Clinical Stage II and III Estrogen Receptor...Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women With Clinical Stage II and III Estrogen Receptor...
Researchers have been studying breast cancer to learn the best way to treat the disease. Chemotherapy (treatment with anti-cancer drugs) is commonly giv
Carcinoma of the bronchus 60 years later | ThoraxCarcinoma of the bronchus 60 years later | Thorax
Radiological examination should never be omitted, but it must be recognized that a carcinoma can occur in one of the larger bronchi without any radiological change in the lung, provided there is insufficient obstruction to interfere with the free inflow and outflow of air to and from the lung beyond. In the majority of cases, however, a shadow will be evident on the film… Enlarged glands are almost invariably present, and it is by no means always easy to determine whether the enlargement is due to infection, secondary growth, or a combination of both. When the glands are enlarged by secondary growth, as is sometimes obvious, the ultimate prognosis is adversely affected, even when all visible glands are removed.1. Perhaps the most important advances in the evaluation of patients with lung cancer have come from better ability to stage patients accurately. The staging classification is extremely important because the correct stage provides both prognostic information and a framework for ...
Effect of mammographic service screening on stage at presentation of breast cancers in Sweden - Fingerprint - Taipei...Effect of mammographic service screening on stage at presentation of breast cancers in Sweden - Fingerprint - Taipei...
Stephen W. Duffy, László Tabár, Tony H H Chen, Robert A. Smith, Lars Holmberg, Håkan Jonsson, Per Lenner, Lennarth Nyström, Sven Törnberg, Jan Frisell, Amy M F Yen, Li Sheng Chen, Yueh Hsiah Chiu, Chia Yuan Wu, Hui Min Wu, Chih Chung Huang, Jane Warwick, Levent Kemetli, Patrick Chou, Gunilla ...
Run The Jewels Were Attacked On Stage At SXSW [Update: Killer Mike Suffers Injury]Run The Jewels Were Attacked On Stage At SXSW [Update: Killer Mike Suffers Injury]
Run The Jewels had a man run up on them while performing on stage at SXSW. While performing down at SXSW in Austin, Texas on Monday, Killer Mike and El-P had...
AJCC Cancer Staging Manual | Mahul B. Amin | SpringerAJCC Cancer Staging Manual | Mahul B. Amin | Springer
The AJCC Cancer Staging Manual is the gold standard to help the cancer patient management team determine the correct stage for patients, allowing for the
Is there a stage 5 cancer - Things You Didnt KnowIs there a stage 5 cancer - Things You Didn't Know
Is there a stage 5 cancer - How long can someone survive at stage five cancer? See below. There are different ways to stage cancer, but stage 5 is not a recognized stage. You may consult this site for information on staging. Https://www. Cancer. Org/treatment/understanding-your-diagnosis/staging. Html
Ovarian Cancer Staging - New Kids CenterOvarian Cancer Staging - New Kids Center
Ovarian cancer staging is an important step in diagnosis to determine the management of the disease and will help in the prediction of the outcome of the cancer.
Read Microsoft Word - 537 544 ObroceaFl TNM staging.docRead Microsoft Word - 537 544 ObroceaFl TNM staging.doc
Readbag users suggest that Microsoft Word - 537_544_ObroceaFl_TNM staging.doc is worth reading. The file contains 8 page(s) and is free to view, download or print.
Beyond Five - Staging and gradingBeyond Five - Staging and grading
Once your doctor has diagnosed cancer, it important to find out how big the cancer is and where it started to grow. They need to see if the cancer has spread to the lymph nodes in the neck (nodal metastases) or other parts of the body such as the lungs, liver or bone (distant metastases). The term used to describe where the cancer has started to grow is called primary and if it spreads to other parts of the body, it is called a secondary or metastases. This is called staging. Staging a cancer is important because it helps your doctor to choose the best treatment for you.. ...
AJCC - AJCC NewsAJCC - AJCC News
As cancer science continues to evolve at a rapid pace, so does the AJCCs role as the preeminent source of cancer staging information. ...
Thijs Van Dalen and Neoplasm Staging - Free people check - Yasni.comThijs Van Dalen and Neoplasm Staging - Free people check - Yasni.com
Check Thijs Van Dalen and Neoplasm Staging: free people check with all available information for the name on the internet, Yasni.com Free People Search
Cancer StagingCancer Staging
Staging is the process of finding out how much cancer there is in the body and where it is located. Doctors use this information to plan treatment and to help predict a persons outlook (prognosis).
PAK1 activation is correlated with tumor stage at prese | Open-iPAK1 activation is correlated with tumor stage at prese | Open-i
PAK1 activation is correlated with tumor stage at presentation. A-Dot plot demonstrating the expression of E-cadherin in the examined tumors in relation to the
AJCC - AJCC Cancer Staging Manual in the LiteratureAJCC - AJCC Cancer Staging Manual in the Literature
Please contact [email protected] if you would like to add more articles to this list.. Articles marked with an asterik (*) offer FREE CME hours. All CE activities offered in CA: A Cancer Journal for Clinicians are FREE of charge. ...
2018 Collin County MLK Unity Walk2018 Collin County MLK Unity Walk
More details coming soon on staging area, starting location and destination. Plan to have your church, organization, Friends & Family prepared to join in and walk in unity on this morning ...
LeAnn Rimes -- Unstable on Stage at X Factor? | TMZ.comLeAnn Rimes -- Unstable on Stage at 'X Factor?' | TMZ.com
LeAnn Rimes took the stage on X Factor last night, and delivered a weird performance that has a lot of people wondering if she hit the bottle before…
Staging and gradingStaging and grading
Staging a cancer involves describing its size, where it is and whether it has spread. Grading the cancer helps understand how quickly it may grow and spread.
Having tumor in under arms even after a surgery. Is it a symptom of cancer ? - Doctors insight on HealthcareMagicHaving tumor in under arms even after a surgery. Is it a symptom of cancer ? - Doctor's insight on HealthcareMagic
Question - Having tumor in under arms even after a surgery. Is it a symptom of cancer ?. Ask a Doctor about Prostate cancer staging, Ask an Oncologist
Analyzing Dramatic Works: Theme, Character Development & Staging - Video & Lesson Transcript | Study.comAnalyzing Dramatic Works: Theme, Character Development & Staging - Video & Lesson Transcript | Study.com
If All the worlds a stage, and all the men and women merely players, then why does analyzing a dramatic script seem so difficult? Find out how...
Aging | Validation of the 8|sup|th|/sup| edition of the American Joint Committee on Cancer Pathological Prognostic Staging for...Aging | Validation of the 8|sup|th|/sup| edition of the American Joint Committee on Cancer Pathological Prognostic Staging for...
Full Text - Purpose: This study aimed to validate the newly proposed American Joint Committee on Cancer (AJCC) pathological prognostic staging system for young breast cancer patients (aged ≤40 years).Results: We included 12811 women in this study. Overall, 52.8% of patients in the 7th AJCC stages were restaged to the 8th AJCC pathological staging system, including 10.7% upstaged and 42.1% downstaged. The receiver operating characteristics analysis showed that the new staging system had a better role in predicting breast cancer-specific survival (BCSS) compared with 7th edition staging (P<0.001). The results of the multivariate prognostic analysis showed that the hazard ratio of BCSS increased with the 8th AJCC stages, while the 7th anatomic stages had no significant difference in BCSS.Conclusions: The novel pathological staging system could provide more accurate prognostic stratification for young women with breast cancer because of the high proportion of stage migration.Patients and Methods:
PRIME PubMed | Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone...PRIME PubMed | Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone...
PubMed journal article: Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone curative resection. Download Prime PubMed App to iPhone, iPad, or Android
How Aggressive Should We Be in Patients With Stage IV Colorectal Cancer? - PubMedHow Aggressive Should We Be in Patients With Stage IV Colorectal Cancer? - PubMed
Whether to perform primary tumor resection in patients with asymptomatic Stage IV colorectal cancer remains controversial; however, the more aggressively we perform radical resection and metastasectomy to selected patients, the more survival benefits the patients obtain.
Genomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor...Genomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor...
BACKGROUND: Identification of high-risk stage II colorectal cancer (CRC) patients, potential candidates for adjuvant chemotherapy, is challenging. Current clinical guidelines rely mainly on histopathological markers with relatively weak prognostic value. This motivates further search for prognostic markers.. METHODS: This explorative study aimed to identify potential candidate gene mutations to facilitate differentiation between subgroups of patients with CRC stage II. Panel-based massive parallel sequencing was used to genetically characterize tumor tissues from 85 patients radically operated for CRC stage II, of which 12 developed recurrent cancer during follow-up. Genetic data was compared between patients with or without cancer recurrence, between tumors located in colon and in rectum, and for association with tumor differentiation grade.. RESULTS: Genetic variation in ATM, C11ORF65 was associated with recurrence-free survival. Previous reports regarding the association between BRAF mutation ...
Refubium - Accuracy of various lymph node staging criteria in rectal cancer with magnetic resonance imagingRefubium - Accuracy of various lymph node staging criteria in rectal cancer with magnetic resonance imaging
Neoadjuvant chemoradiation decreases the risk of local recurrence in locally advanced rectal cancer and is therefore indicated by guidelines in patients with positive nodal status (cN+) or cT3/4 tumors. On the other hand is neoadjuvant chemoradiation associated with relevant side effects and long term complications such as loss of sexual activity and fecal incontinence. However, accuracy of routine pretherapeutic lymph node staging (cN) in rectal cancer with MR imaging is still limited which can lead to overstaging and overtreatment. Few studies have shown a distinct improvement of the diagnostic accuracy of nodal staging (cN) by applying morphologic criteria (altered border contour and inhomogeneous signal intensity) instead of the established size criterion. The aim of the study was to determine and compare accuracy, sensitivity and specificity of the size criterion and morphological criteria in nodal staging. LN in preoperative MRI of 60 patients with rectal cancer and primary surgery that ...
Universidade do Minho: Preoperative staging of rectal cancer with MRI: correlation with pathologic stagingUniversidade do Minho: Preoperative staging of rectal cancer with MRI: correlation with pathologic staging
INTRODUCTION] An accurate preoperative rectal cancer staging is crucial to the correct management of the disease. Despite great controversy around this issue, pelvic magnetic resonance (RM) is said to be the imagiologic standard modality. This work aimed to evaluate magnetic resonance accuracy in preoperative rectal cancer staging comparing with the anatomopathological results. METHODS We calculated sensibility, specificity, positive (VP positive) and negative (VP negative) predictive values for each T and N. We evaluated the concordance between both methods of staging using the Cohen weighted K (Kw), and through ROC curves, we evaluated magnetic resonance accuracy in rectal cancer staging. RESULTS 41 patients met the inclusion criteria. We achieved an efficacy of 43.9% for T and 61% for N staging. The respective sensibility, specificity, positive and negative predictive values are 33.3%, 94.7%, 33.3% and 94.7% for T1; 62.5%, 32%, 37.0% and 57.1% for T2; 31.8%, 79%, 63.6% and 50% for T3 and ...
Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer - Full Text View - ClinicalTrials...Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer - Full Text View - ClinicalTrials...
OUTLINE: Patients receive vaccination comprising HER-2-neu and carcinoembryonic antigen synthetic peptides, sargramostim (GM-CSF), and Montanide ISA-51 on days 1, 8, and 15. On day 22, patients undergo removal of the lymph node into which the vaccination site drains to determine whether the immune system is responding to the vaccine.. PROJECTED ACCRUAL: A maximum of 15 patients will be accrued for this study. ...
Breast Cancer Stage 3 Treatment Options | Modern Cancer Hospital Guangzhou, ChinaBreast Cancer Stage 3 Treatment Options | Modern Cancer Hospital Guangzhou, China
Breast cancer stage 3 describes the breast cancer has extend to the underarm lymph nodes and muscles but not spread to more distant sites in the body. This stage is divided into three groups, breast cancer stage 3A, 3B and 3C.
Breast Cancer Stage 4 Treatment Options | Modern Cancer Hospital Guangzhou, ChinaBreast Cancer Stage 4 Treatment Options | Modern Cancer Hospital Guangzhou, China
Surgery and radiotherapy may not be suitable for most breast cancer stage 4 patients. Here are the suggested treatment options for patients with breast cancer stage 4.
Stage III Breast Cancer | Texas OncologyStage III Breast Cancer | Texas Oncology
Stage III breast cancer requires local therapy such as surgery and/or radiation and systemic therapy such as chemotherapy, hormonal or biological therapy.
Elevated ALCAM Shedding in Colorectal Cancer Correlates with Poor Patient Outcome | Cancer ResearchElevated ALCAM Shedding in Colorectal Cancer Correlates with Poor Patient Outcome | Cancer Research
Colorectal cancer (CRC) is the third most frequently diagnosed cancer, and second leading cause of cancer-related deaths in the United States (1). Current prognosis for patients with CRC predominantly relies on pathologic Unio Internationale Contra Cancrum/American Joint Committee on Cancer (UICC/AJCC) tumor-node-metastasis (TNM) staging classification (2). Although TNM staging successfully stratifies high-risk patients, there is significant variability in the rate of disease progression within each stage. Particular concern exists for early-stage disease (stage I and II) where patients can progress more rapidly than expected. It is well known that approximately 30% of patients with stage II CRC die of recurrent and metastatic disease. Identification of patients at risk of recurrence/progression could inform clinicians on adjuvant chemotherapeutic treatment decisions. Biomarkers can assist in identifying those patients who require more aggressive intervention or patients at risk of relapse after ...
A Patient-Centered Methodology That Improves the Accuracy of Prognostic Predictions in CancerA Patient-Centered Methodology That Improves the Accuracy of Prognostic Predictions in Cancer
Individualized approaches to prognosis are crucial to effective management of cancer patients. We developed a methodology to assign individualized 5-year disease-specific death probabilities to 1,222 patients with melanoma and to 1,225 patients with breast cancer. For each cancer, three risk subgroups were identified by stratifying patients according to initial stage, and prediction probabilities were generated based on the factors most closely related to 5-year disease-specific death. Separate subgroup probabilities were merged to form a single composite index, and its predictive efficacy was assessed by several measures, including the area (AUC) under its receiver operating characteristic (ROC) curve. The patient-centered methodology achieved an AUC of 0.867 in the prediction of 5-year disease-specific death, compared with 0.787 using the AJCC staging classification alone. When applied to breast cancer patients, it achieved an AUC of 0.907, compared with 0.802 using the AJCC staging classification
Sparrho | Lymph node density vs. the American Joint Committee on CancSparrho | Lymph node density vs. the American Joint Committee on Canc
We compared the prognostic value of the American Joint Committee on Cancer (AJCC) TNM nodal staging system with that of lymph node (LN) density in patients with
Microrna-9-5p-CDX2 axis: A useful prognostic biomarker for patients with stage II/III colorectal cancer<...Microrna-9-5p-CDX2 axis: A useful prognostic biomarker for patients with stage II/III colorectal cancer<...
TY - JOUR. T1 - Microrna-9-5p-CDX2 axis. T2 - A useful prognostic biomarker for patients with stage II/III colorectal cancer. AU - Nishiuchi, Aya. AU - Hisamori, Shigeo. AU - Sakaguchi, Masazumi. AU - Fukuyama, Keita. AU - Hoshino, Nobuaki. AU - Itatani, Yoshiro. AU - Honma, Shusaku. AU - Maekawa, Hisatsugu. AU - Nishigori, Tatsuto. AU - Tsunoda, Shigeru. AU - Obama, Kazutaka. AU - Miyoshi, Hiroyuki. AU - Shimono, Yohei. AU - Mark Taketo, M.. AU - Sakai, Yoshiharu. PY - 2019/12. Y1 - 2019/12. N2 - A lack of caudal-type homeobox transcription factor 2 (CDX2) protein expression has been proposed as a prognostic biomarker for colorectal cancer (CRC). However, the relationship between CDX2 levels and the survival of patients with stage II/III CRC along with the relationship between microRNAs (miRs) and CDX2 expression are unclear. Tissue samples were collected from patients with stage II/III CRC surgically treated at Kyoto University Hospital. CDX2 expression was semi-quantitatively evaluated by ...
Colon cancer staging - WikipediaColon cancer staging - Wikipedia
The most common staging system is the TNM (for tumors/nodes/metastases) system, from the American Joint Committee on Cancer (AJCC). The TNM system assigns a number based on three categories. "T" denotes the degree of invasion of the intestinal wall, "N" the degree of lymphatic node involvement, and "M" the degree of metastasis. Possibly, the The overall AJCC stage is a shorter format of the TNM stage, and is usually quoted as a number I, II, III, IV derived from the TNM value grouped by prognosis; a higher number indicates a more advanced cancer and likely a worse outcome. Following is the eighth edition from 2017: ...
Modest value of staging investigations in heavily node positive early breast cancer patients | OncologyPROModest value of staging investigations in heavily node positive early breast cancer patients | OncologyPRO
Background Staging investigations for metastatic disease are not recommended for asymptomatic patients with early breast cancer. However, it is relatively common practice to perform staging in patients who are heavily node positive (4 or more nodes involved). This study explored the benefit of routine investigations in this patient group.. Methodology All patients operated in Castle Hill Hospital, Hull, UK between January 2005 and December 2011 for early breast cancer and found to have 4 or more nodes involved on pathological assessment were identified. Staging investigations, consisting of CT chest, abdomen and pelvis and isotope bone scan, were reviewed. The need for additional investigations was recorded.. Results A total of 231 patients were identified. 59 patients were excluded as no staging investigations were performed. In the remaining 172 patients staging investigations were positive in 12% (21/172). An additional 17% (29/172) required further investigations for equivocal scans and were ...
Patient Resource Publishing : Head and Neck Thyroid ::.Patient Resource Publishing : Head and Neck Thyroid ::.
Staging is how physicians determine the extent of your cancer, where it is located, and whether it has metastasized to nearby organs or tissue or to other parts of your body.. The TNM staging system, developed by the American Joint Committee on Cancer (AJCC), is typically used to stage head and neck cancers. This system classifies the cancer by tumor (T), node (N) and metastasis (M). The T category describes the size and location of the primary tumor. The N category describes lymph node involvement, indicating whether the lymph nodes show evidence of cancer cells. The location of these lymph nodes is important because it shows how far the disease has spread. The pathologic N category (sometimes denoted as pN) describes how many lymph nodes are involved and the amount of tumor cells found in the nodes. The M category describes distant metastasis (spread of cancer to another part of the body), if any. Staging for the M category is mainly clinical; however, a new M subcategory may be given based on ...
MOL] Effective imaging study for determining the T and N stages of esop [00884]MOL] Effective imaging study for determining the T and N stages of esop [00884]
Endoscopic ultrasonography (EUS) is the single best modality for staging esophageal cancer with respect to depth of tumor infiltration and extent of lymph node involvement using the TNM classification system. The accuracy of EUS for staging patients with esophageal carcinoma who subsequently underwent surgery for confirmation ranged from 59% to 92% (with a mean of 84% in 1154 patients); the accuracy for N staging ranged from 50% to 90% (with a mean of 77% in 1035 patients). Endosonography is superior to CT in the T and N staging of disease. However, EUS is not a sensitive tool for diagnosing tumor involvement of the trachea and bronchial tree, because these structures contain air. Bronchoscopy should be used for the staging of proximal esophageal cancers. If esophageal cancers obstruct the lumen and the EUS endoscope cannot be advanced through, tumor staging is incomplete. EUS employs the technology of endoscopy and internally placed high-frequency ultrasound waves to visualize the ...
Clinical implications of endoscopic ultrasonography non-traversability in patients with locoregional esophageal cancer...Clinical implications of endoscopic ultrasonography non-traversability in patients with locoregional esophageal cancer...
In addition, the prognosis of our patients with EUS non-traversable EC may have been further worsened by the limited EUS assessment of EC stage. EUS is a standard locoregional staging modality for EC, demonstrating high T (80% to 90%) and N staging accuracy (70% to 80%) that is clearly superior to CT and magnetic resonance imaging [3,4]. However, the accuracy of EUS decreases significantly when an echoendoscope cannot pass through EC. Staging accuracy of EUS is reportedly 46% in EUS non-traversable EC (vs. 92% in EUS traversable EC) and correct preoperative T stage was obtained using EUS only in 30.8% of patients with high-grade EC stenosis (vs. 81% of patients with less severe EC stenosis) [6,22]. A previous study reported that 9.9% of patients with distant metastatic nodes were found on EUS after EC stenosis dilation [23]. Another study on the effects of EUS after dilation of EC stenosis reported that EUS detected additional cases of advanced diseases in 19% of patients, including celiac node ...
NCCN Quick Guide™ | Breast Cancer - Stage IVNCCN Quick Guide™ | Breast Cancer - Stage IV
1 of 2 NCCN QUICK GUIDE tm Breast Cancer - Metastatic (STAGE IV), Version 1.2017 This NCCNQUICK GUIDE tm sheet summarizes key points from the complete NCCN Guidelines for Patients ® : Breast Cancer - Metastatic (STAGE IV) . These guidelines explain which tests and treatments are recommended by experts in cancer. To view and download the guidelines, visit NC C N.or g /patients or, to order printed copies, visit Amazon.com. What is metastatic breast cancer? It is cancer that has spread outside the breast to a distant site. Distant sites include bones, lungs, liver, and the brain. Stage IV breast cancer is metastatic cancer that was found at diagnosis. 12 What health care is needed before treatment? ■ A report of your health history and an exam of your body 14 ■ Blood tests to check for health problems 15 ■ Pictures of the insides of your chest with a CT scan 16 ■ Pictures of the insides of your belly area and maybe pelvis with CT or MRI scans 16 ■ Pictures of your spine, brain, or both ...
Prevention and Treatment of Cancer-Related Infections in: Journal of the National Comprehensive Cancer Network Volume 6 Issue 2...Prevention and Treatment of Cancer-Related Infections in: Journal of the National Comprehensive Cancer Network Volume 6 Issue 2...
As the worlds oldest and largest private cancer center, Memorial Sloan-Kettering Cancer Center (MSKCC) is committed to exceptional patient care, leading-edge research, and superb educational programs. The close collaboration between its physicians and scientists is one of the Centers core strengths. At Sloan-Kettering Institute, state-of-the-art research flourishes side-by-side with clinical investigation and treatment at Memorial Hospital, the nations oldest cancer hospital. An essential component of MSKCCs mission is education-training future clinicians and scientists and providing unique programs in the study of biomedical sciences to advance the standard of cancer care worldwide.The Center has more than 9,000 employees and last year had more than 21,000 inpatient admissions. The Center accommodated more than 430,000 outpatient visits at its Manhattan and regional sites combined.Robert E. Wittes, MD (second picture on the cover), is Physician-in-Chief of Memorial Hospital. A graduate of ...
ajcc stage ii rectal cancer 2005:2010[pubdate] *count=100 - BioMedLib™ search engineajcc stage ii rectal cancer 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
PATIENTS AND METHODS: Ten potential prognostic factors were investigated in 94 patients receiving radiotherapy for recurrent rectal cancer: age (,or=68 vs. ,or=69 years), gender, Eastern Cooperative Oncology Group performance status (0-1 vs. 2-3), American Joint Committee on Cancer (AJCC) stage (,or=II vs. III vs. IV), grading (G1-2 vs. G3), surgery, administration of chemotherapy, radiation dose (equivalent dose in 2-Gy fractions: ,or=50 vs. ,50 Gy), and hemoglobin levels before (,12 vs. ,or=12 g/dL) and during (majority of levels: ,12 vs. ,or=12 g/dL) radiotherapy ...
A phase II study of AZD2171 [cediranib] in breast cancer stage IV (10006202) - AdisInsightA phase II study of AZD2171 [cediranib] in breast cancer stage IV (10006202) - AdisInsight
This study is investigating the efficacy and safety of cediranib [AZD2171; Recentin] in patients with breast cancer stage IV. The primary endpoints are outcomes
ajcc stage iv rectal cancer 2005:2010[pubdate] *count=100 - BioMedLib™ search engineajcc stage iv rectal cancer 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
PATIENTS AND METHODS: Ten potential prognostic factors were investigated in 94 patients receiving radiotherapy for recurrent rectal cancer: age (,or=68 vs. ,or=69 years), gender, Eastern Cooperative Oncology Group performance status (0-1 vs. 2-3), American Joint Committee on Cancer (AJCC) stage (,or=II vs. III vs. IV), grading (G1-2 vs. G3), surgery, administration of chemotherapy, radiation dose (equivalent dose in 2-Gy fractions: ,or=50 vs. ,50 Gy), and hemoglobin levels before (,12 vs. ,or=12 g/dL) and during (majority of levels: ,12 vs. ,or=12 g/dL) radiotherapy ...
Stages of Breast Cancer - Stages of Condition | Susan G. Komen®Stages of Breast Cancer - Stages of Condition | Susan G. Komen®
Breast cancer stages help determine your treatment. In general, the earlier the stage of breast cancer, the better the prognosis will be.
Stage II Colon Cancer | Texas OncologyStage II Colon Cancer | Texas Oncology
Despite undergoing complete surgical removal of the cancer, 25-40% of patients with Stage II colon carcinoma experience recurrence of their cancer.
Molecular staging individualizing cancer management - Mejia - 2012 - Journal of Surgical Oncology - Wiley Online LibraryMolecular staging individualizing cancer management - Mejia - 2012 - Journal of Surgical Oncology - Wiley Online Library
Although the most important prognostic and predictive marker in colorectal cancer is tumor cells in lymph nodes, ∼30% of patients who are node-negative die from occult metastases. Molecular staging employing specific markers and sensitive detection technologies has emerged as a powerful platform to assess prognosis in node-negative colon cancer. Integrating molecular staging into algorithms that individualize patient management will require validation and the definition of relationships between occult tumor cells, prognosis, and responses to chemotherapy. J. Surg. Oncol. 2012; 105:468-474. © 2012 Wiley Periodicals, Inc. ...
Efikasnost lečenja bolesnika u IIIA stadijumu nemikrocelularnog karcinoma bronha operisanih nakon neoadjuvantne terapijeEfikasnost lečenja bolesnika u IIIA stadijumu nemikrocelularnog karcinoma bronha operisanih nakon neoadjuvantne terapije
of response to neoadjuvant therapy in stage IIIA NSCLC patients in relation to T factor and N factor; evaluation of TNM classification before and after use of neoadjuvant therapy in stage IIIA NSCLC patients; determination of degree of tumor regression with pathohistologic analysis of resection specimen of NSCLC obtained from patients after application of neoadjuvant therapy, as a prognostic factor for disease-free period and overall survival rate; and determination of degree of tumor regression in malignant lymph nodes after application of neoadjuvant therapy in stage IIIA NSCLC patients, as a prognostic factor for disease-free period and overall survival rate. Results have shown that neoadjuvant therapy according to RECIST criteria leads to significant reduction of tumor size, T factors, as well as significant downstaging of nodal status, N factor, in treatment of stage IIIA NSCLC patients. Furthermore, neoadjuvant therapy according to RECIST criteria leads to significant reduction of clinical ...
Predicting the prognosis of lung cancer: The evolution of tumor, node and metastasis in the molecular age-challenges and...Predicting the prognosis of lung cancer: The evolution of tumor, node and metastasis in the molecular age-challenges and...
TY - JOUR. T1 - Predicting the prognosis of lung cancer. T2 - The evolution of tumor, node and metastasis in the molecular age-challenges and opportunities. AU - Rami-Porta, Ramón. AU - Asamura, Hisao. AU - Goldstraw, Peter. PY - 2015. Y1 - 2015. N2 - The tumor, node and metastasis (TNM) classification of malignant tumors was proposed by Pierre Denoit in the mid-20th century to code the anatomic extent of tumors. Soon after, it was accepted by the Union for International Cancer Control and by the American Joint Committee on Cancer, and published in their respective staging manuals. Till 2002, the revisions of the TNM classification were based on the analyses of a database that included over 5,000 patients, and that was managed by Clifton Mountain. These patients originated from North America and almost all of them had undergone surgical treatment. To overcome these limitations, the International Association for the Study of Lung Cancer proposed the creation of an international database of lung ...
Better survival in right-sided versus left-sided stage I - III colon cancer patients | BMC Cancer | Full TextBetter survival in right-sided versus left-sided stage I - III colon cancer patients | BMC Cancer | Full Text
Currently, data regarding the prognosis of right-sided versus left-sided colon cancer are conflicting, however, most studies revealed a poorer survival in right-sided primary tumor location [14-18, 29].. To our knowledge this is the first population-based, propensity score adjusted analysis investigating the prognostic impact of tumor location in non-metastatic colon cancer patients. Being aware of the conflicting data and also of the challenges to handle relevant bias due to substantial imbalances regarding baseline characteristics between right- and left-sided colon cancer patients, we have intentionally selected the propensity score matching as a further statistical method in addition to common multivariate analysis to minimize confounding. In the present analysis, the cohort was partitioned into subgroups containing one or more patients with right-sided colon cancer who were matched to one or more patients with left-sided colon cancer with similar values on the observed covariates in the ...
Gene expression profiles as predictors of poor outcomes in stage II colorectal cancer: A systematic review and meta-analysisGene expression profiles as predictors of poor outcomes in stage II colorectal cancer: A systematic review and meta-analysis
This analysis demonstrates the promising potential of using GEP assays as predictors of poor outcomes in stage II CRC, such as cancer recurrence or death. To maximize their utility and availability, further studies will be needed to identify and validate specific gene signatures for poor prognosis i …
svn commit: r838378 - in /websites/staging/ctakes/trunk/content: ./ ctakes/3.0.0/user-guide-3.0.htmlsvn commit: r838378 - in /websites/staging/ctakes/trunk/content: ./ ctakes/3.0.0/user-guide-3.0.html
Author: buildbot Date: Wed Nov 14 22:10:56 2012 New Revision: 838378 Log: Staging update by buildbot for ctakes Modified: websites/staging/ctakes/trunk/content/ (props changed) websites/staging/ctakes/trunk/content/ctakes/3.0.0/user-guide-3.0.html Propchange: websites/staging/ctakes/trunk/content/ ------------------------------------------------------------------------------ --- cms:source-revision (original) +++ cms:source-revision Wed Nov 14 22:10:56 2012 @@ -1 +1 @@ -1409471 +1409472 Modified: websites/staging/ctakes/trunk/content/ctakes/3.0.0/user-guide-3.0.html ============================================================================== --- websites/staging/ctakes/trunk/content/ctakes/3.0.0/user-guide-3.0.html (original) +++ websites/staging/ctakes/trunk/content/ctakes/3.0.0/user-guide-3.0.html Wed Nov 14 22:10:56 2012 @@ -148,10 +148,9 @@ there. This example file can also be fou ,pre, Dr. Nutritious   -Medical Nutrition Therapy for Hyperlipidemia,/p, -,/li, -,/ol, -,p,Referral from: ...
Variations of discordance of the clinical TNM stage with the pathological TNM stage between Japanese designated cancer...Variations of discordance of the clinical TNM stage with the pathological TNM stage between Japanese designated cancer...
Introduction Previous studies showed that TNM stages that were clinically determined before surgery were not often concordant with pathological TNM stages. However, no previous studies have examined variations of discordance of the clinical TNM stage with the pathological TNM stage among hospitals. We aimed to examine the discordance of the clinical and pathological stages among Japanese designated cancer hospitals using compiled data from the hospital-based cancer registry submitted from 286 designated cancer care hospitals in Japan.. Methods The registry data had UICC TNM stages before and after surgery for stomach, colorectal, lung and breast cancer patients treated in these hospitals. We excluded patients who received adjuvant chemotherapy or radiotherapy, patients who received care from facilities with less than 10 patients, male breast cancer and patients whose stages were unknown from the analysis. We also calculated discordance of stages that could have theoretically resulted in changes ...
Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast CancerCombination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from div
Video Gallery : Diseases of the Colon & RectumVideo Gallery : Diseases of the Colon & Rectum
Watson for Oncology produced therapeutic options highly concordant with human decisions at a top-tier cancer center in China. Treatment patterns suggest that Watson for Oncology may be able to guide clinicians to minimize overtreatment of patients with high-risk stage II colon cancer with chemotherapy. Survival analyses suggest the need for further investigation to specifically assess the association between surveillance, single-agent and multiagent chemotherapy, and survival outcomes in this population. ...
Lung cancer staging undergoes major overhaulLung cancer staging undergoes major overhaul
The imminent publication of eagerly anticipated new international guidelines promises to transform the complex area of lung cancer staging.
On Stage Pair of Near-Field Studio Monitor Stands with Weighted Hex BaseOn Stage Pair of Near-Field Studio Monitor Stands with Weighted Hex Base
... - On Stage - Professional Studio Monitor Stands adjust from 36.5 - 54 in height to customize your listening area. The stands feature a heavy duty stamped Hex-Base, which provides a stable foundation and can hold up to 90 lbs per stand. Rubber feet and EVA rubber on t
ISBNs for neoplasms classificationISBNs for neoplasms classification
9780387884424, titled AJCC Cancer Staging Handbook: From the Ajcc Cancer Staging Manual , 7 edition (Springer Verlag, November 5, 2009), cover price $44.95 , About this edition: Used by physicians and health care professionals worldwide to facilitate the uniform description of neoplastic diseases, the fully revised and updated Seventh Edition of the AJCC Cancer Staging Handbook brings together all currently available information on staging of cancer at various anatomic sites and incorporates newly acquired knowledge on the etiology and pathology of cancer ...
Molecular profiles and clinical outcome of stage UICC II colon cancer patients | SpringerLinkMolecular profiles and clinical outcome of stage UICC II colon cancer patients | SpringerLink
Published multigene classifiers suggesting outcome prediction for patients with stage UICC II colon cancer have not been translated into a clinical application so far. Therefore, we aimed at validatin
Neuroendocrine tumorNeuroendocrine tumor
Analgesic nephropathyAnalgesic nephropathy
Renal cell carcinomaRenal cell carcinoma
EndoglinEndoglin
Endoscopic submucosal dissectionEndoscopic submucosal dissection
NeoplasmNeoplasm
Eye neoplasmEye neoplasm
Microarray analysis techniquesMicroarray analysis techniques
Papillary urothelial neoplasm of low malignant potentialPapillary urothelial neoplasm of low malignant potential
Eye neoplasmEye neoplasm
CarcinomaCarcinoma
Virtual karyotypeVirtual karyotype
SeminomaSeminoma
MyometriumMyometrium
Digestive system neoplasmDigestive system neoplasm
Vulvar cancerVulvar cancer
Breast augmentationBreast augmentation
Grading (tumors)Grading (tumors)
CarcinomaCarcinoma
Blood in stoolBlood in stool
Esophageal cancerEsophageal cancer
Pilocytic astrocytomaPilocytic astrocytoma
Chronic myelogenous leukemiaChronic myelogenous leukemia
Neuronal lineage markerNeuronal lineage marker
Gleason grading systemGleason grading system
Small-cell carcinomaSmall-cell carcinoma
Camran NezhatCamran Nezhat
CancerCancer
PlicamycinPlicamycin
YM BiosciencesYM Biosciences
PAX8PAX8
Brain tumorBrain tumor
Index of HIV/AIDS-related articlesIndex of HIV/AIDS-related articles
ICD-10 Chapter V: Mental and behavioural disordersICD-10 Chapter V: Mental and behavioural disorders
පිළිකා - විකිපීඩියා, නිදහස් විශ්වකෝෂයපිළිකා - විකිපීඩියා, නිදහස් විශ්වකෝෂය
Indigenous AustraliansIndigenous Australians
Platelet-derived growth factorPlatelet-derived growth factor
Radiation therapyRadiation therapy
Bugspytkirtelkræft, den frie encyklopædiBugspytkirtelkræft, den frie encyklopædi
سرطان پروستات - ویکی‌پدیا، دانشنامهٔ آزادسرطان پروستات - ویکی‌پدیا، دانشنامهٔ آزاد
ಮೆದುಳಿನ ಕ್ಯಾನ್ಸರ್ ಗೆಡ್ದೆ(ಊತ) - ವಿಕಿಪೀಡಿಯಮೆದುಳಿನ ಕ್ಯಾನ್ಸರ್ ಗೆಡ್ದೆ(ಊತ) - ವಿಕಿಪೀಡಿಯ
FolateFolate
ThymusThymus
Acute lymphoblastic leukemiaAcute lymphoblastic leukemia
p21p21
Non-small-cell lung carcinomaNon-small-cell lung carcinoma
Primary myelofibrosisPrimary myelofibrosis
ChemotherapyChemotherapy
CpG siteCpG site
Rathkes pouchRathke's pouch
Altered level of consciousnessAltered level of consciousness
Cell damageCell damage
CT scanCT scan
Brain tumorBrain tumor
AutopsyAutopsy
CDH1 (gene)CDH1 (gene)
AnatomyDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsInformation ScienceHealth Care
Neoplasm StagingPancreatic NeoplasmsNeoplasmsEndosonographyLymphatic MetastasisSkin NeoplasmsNeoplasms, Cystic, Mucinous, and SerousTomography, X-Ray ComputedPrognosisLung NeoplasmsFluorodeoxyglucose F18Positron-Emission TomographyNeoplasms, Multiple PrimaryRadiopharmaceuticalsLiver NeoplasmsKidney NeoplasmsRetrospective StudiesLymph NodesSensitivity and SpecificityNeoplasm InvasivenessThyroid NeoplasmsNeoplasms, Second PrimaryAdenocarcinoma, MucinousAdenocarcinomaMediastinumMediastinoscopyStomach NeoplasmsGastrointestinal NeoplasmsLymphomaImmunohistochemistryTumor Markers, BiologicalParotid NeoplasmsOvarian NeoplasmsColorectal NeoplasmsDNA, NeoplasmNeoplasm MetastasisNeoplasm Recurrence, LocalRectal NeoplasmsMyeloproliferative DisordersMediastinal NeoplasmsBile Duct NeoplasmsBone NeoplasmsPredictive Value of TestsLymph Node ExcisionNose NeoplasmsBiopsy, NeedleSentinel Lymph Node BiopsyCarcinomaSurvival AnalysisCarcinoma, PapillaryEye NeoplasmsEsophageal NeoplasmsCystadenomaNeoplasms, Connective and Soft TissueAbdominal NeoplasmsNeoplasms, Plasma CellCarcinoma, Pancreatic DuctalThymus NeoplasmsMagnetic Resonance ImagingAppendiceal NeoplasmsMultimodal ImagingAdenocarcinoma, PapillarySoft Tissue NeoplasmsNeoplasms, Glandular and EpithelialCystadenoma, MucinousUterine NeoplasmsBreast NeoplasmsBiopsy, Fine-NeedleColonic NeoplasmsTreatment OutcomeBone Marrow NeoplasmsPreoperative CareEndocrine Gland NeoplasmsNeoplasm ProteinsBiopsyIntestinal NeoplasmsNeoplasms, ExperimentalMouth NeoplasmsProspective StudiesNeoplasms, Vascular TissueFollow-Up StudiesAdenomaTomography, Emission-ComputedSalivary Gland NeoplasmsSplenic NeoplasmsNeoplasms, Radiation-InducedHodgkin DiseaseReproducibility of ResultsCarcinoma, Squamous CellAntigens, NeoplasmDuodenal NeoplasmsTesticular NeoplasmsNeoplasms, Muscle TissuePleural NeoplasmsCystadenocarcinoma, MucinousGallbladder NeoplasmsUrinary Bladder NeoplasmsMelanomaHematologic NeoplasmsTongue NeoplasmsNeuroendocrine TumorsNeoplasms, Adnexal and Skin AppendageLaparotomyVascular NeoplasmsCommon Bile Duct NeoplasmsSweat Gland NeoplasmsNeoplasms, Germ Cell and EmbryonalLymphographyPalatal NeoplasmsDigestive System NeoplasmsPeritoneal NeoplasmsNeoplasms, Complex and MixedAxillaPelvic NeoplasmsHead and Neck NeoplasmsMandibular NeoplasmsCystadenocarcinomaMuscle NeoplasmsDiagnostic ImagingCombined Modality TherapyProstatic NeoplasmsThoracic NeoplasmsFalse Negative ReactionsEndometrial NeoplasmsWhole Body ImagingHeart NeoplasmsNeoplasm GradingCystadenoma, SerousMaxillary NeoplasmsPreoperative PeriodDisease ProgressionPancreatectomyDog DiseasesCarcinoma, Non-Small-Cell LungAnal Gland NeoplasmsAdenoma, OxyphilicCerebellar NeoplasmsNeoplasms, Adipose TissueLaparoscopyBronchial NeoplasmsMeningeal NeoplasmsParanasal Sinus NeoplasmsDisease-Free SurvivalTime FactorsKaplan-Meier EstimateAdrenal Cortex NeoplasmsLaryngeal NeoplasmsOrbital NeoplasmsIleal NeoplasmsSarcomaCarcinoma, HepatocellularNasopharyngeal NeoplasmsCarcinoma, Acinar CellSpinal Cord NeoplasmsVaginal NeoplasmsAdrenal Gland NeoplasmsNervous System NeoplasmsPenile NeoplasmsNeoplasm SeedingCohort StudiesGenital Neoplasms, FemaleJanus Kinase 2Neoadjuvant TherapyThymomaLiver Neoplasms, ExperimentalHemangiosarcomaAdenocarcinoma, FollicularLeiomyosarcomaMyelodysplastic-Myeloproliferative DiseasesSpinal NeoplasmsPeripheral Nervous System NeoplasmsCerebral Ventricle NeoplasmsLymphoma, T-CellBronchoscopyCarcinoma, NeuroendocrineNeck DissectionUterine Cervical NeoplasmsCarcinoma, BronchogenicCarcinosarcomaPancreaticoduodenectomyEndoscopic Ultrasound-Guided Fine Needle AspirationRisk FactorsMultivariate AnalysisRNA, NeoplasmLipomaCarcinoma, Renal CellFacial NeoplasmsFalse Positive ReactionsLymphatic DiseasesBone Marrow ExaminationFatal OutcomeGastrectomyNeoplasm TransplantationProportional Hazards ModelsRadiotherapy, AdjuvantNeoplasms by SiteIncidental FindingsCarcinoembryonic AntigenHistiocytic Disorders, MalignantImmunoenzyme TechniquesLymphoma, B-Cell
Thijs Van Dalen and Neoplasm Staging - Free people check - Yasni.comThijs Van Dalen and Neoplasm Staging - Free people check - Yasni.com
Staging Systems for Musculoskeletal NeoplasmsStaging Systems for Musculoskeletal Neoplasms
Endoscopic Ultrasound Staging of Periampullary Neoplasms: Retrospective - Tabular View - ClinicalTrials.govEndoscopic Ultrasound Staging of Periampullary Neoplasms: Retrospective - Tabular View - ClinicalTrials.gov
Neoplasm staging | definition of Neoplasm staging by Medical dictionaryNeoplasm staging | definition of Neoplasm staging by Medical dictionary
Search Results for neoplasm staging | JNCCNSearch Results for "neoplasm staging" | JNCCN
Contemporary Grading and Staging of Urothelial Neoplasms of the Urinary Bladder: New Concepts and Approaches to Challenging...Contemporary Grading and Staging of Urothelial Neoplasms of the Urinary Bladder: New Concepts and Approaches to Challenging...
Transanal minimally invasive surgery (TAMIS) for local excision of benign neoplasms and early-stage rectal cancer: efficacy and...Transanal minimally invasive surgery (TAMIS) for local excision of benign neoplasms and early-stage rectal cancer: efficacy and...
Neurokinin A levels predict survival in patients with stage IV well differentiated small bowel neuroendocrine neoplasmsNeurokinin A levels predict survival in patients with stage IV well differentiated small bowel neuroendocrine neoplasms
Predictive Effect of the Total Number of Examined Lymph Nodes on N Staging and Survival in Pancreatic Neuroendocrine NeoplasmsPredictive Effect of the Total Number of Examined Lymph Nodes on N Staging and Survival in Pancreatic Neuroendocrine Neoplasms
Soluble VCAM-1 and Its Relation to Clinical Staging and Histological Grading in Neuroendocrine Neoplasms (NENs)Soluble VCAM-1 and Its Relation to Clinical Staging and Histological Grading in Neuroendocrine Neoplasms (NENs)
Ascorbic acid Withdrawn Phase 2 Trials for Stage II Multiple Myeloma / Refractory Plasma Cell Neoplasm / Stage I Multiple...Ascorbic acid Withdrawn Phase 2 Trials for Stage II Multiple Myeloma / Refractory Plasma Cell Neoplasm / Stage I Multiple...
Number and Localization of Positive Lymph Nodes Correlate with Recurrence in Nonfunctioning Pancreatic Neuroendocrine Neoplasms...Number and Localization of Positive Lymph Nodes Correlate with Recurrence in Nonfunctioning Pancreatic Neuroendocrine Neoplasms...
Staging of urinary bladder neoplasms with MR imaging: is Gd-DTPA helpful? - Semantic ScholarStaging of urinary bladder neoplasms with MR imaging: is Gd-DTPA helpful? - Semantic Scholar
Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on...Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on...
Grading Staging Report -Rectum Carcinoid / Well Differentiated Neuroendocrine Neoplasm/Tumor - Surgical Pathology Criteria -...Grading Staging Report -Rectum Carcinoid / Well Differentiated Neuroendocrine Neoplasm/Tumor - Surgical Pathology Criteria -...
Neoplasm Staging | REACHNeoplasm Staging | REACH
Malignant Neoplasm of the Urinary Bladder Stage 4B: Symptoms, Diagnosis and Treatment - SymptomaMalignant Neoplasm of the Urinary Bladder Stage 4B: Symptoms, Diagnosis and Treatment - Symptoma
Endoscopic ultrasonography in the diagnosis and staging of neoplasms of the head and neck<...Endoscopic ultrasonography in the diagnosis and staging of neoplasms of the head and neck<...
Discrimination of capsular stage brain abscesses from necrotic or cystic neoplasms using diffusion-weighted magnetic resonance...Discrimination of capsular stage brain abscesses from necrotic or cystic neoplasms using diffusion-weighted magnetic resonance...
Diagnosis and Staging of Solid Pancreatic Neoplasms<...Diagnosis and Staging of Solid Pancreatic Neoplasms<...
Tongue Neoplasm Malignant Stage Unspecified : Cetuximab Vs. Cisplatin Drugs - DrugInformerTongue Neoplasm Malignant Stage Unspecified : Cetuximab Vs. Cisplatin Drugs - DrugInformer
Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®) (Patients) | OncoLinkPlasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®) (Patients) | OncoLink
Epidermal growth factor receptor, c-kit, and her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms...Epidermal growth factor receptor, c-kit, and her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms...
Epidermal growth factor receptor, c-kit, and her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms...Epidermal growth factor receptor, c-kit, and her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms...
nature.com searchnature.com search
nature.com searchnature.com search
Pine embryos at various developmental stages emerging from inhibited needle-callus (neoplasm)Pine embryos at various developmental stages emerging from inhibited needle-callus (neoplasm)
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 - NewsemiaRadical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 - Newsemia
Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and Healthy Controls - Full Text View -...Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and 'Healthy Controls' - Full Text View -...
Chronic Myeloproliferative Neoplasms | Vanderbilt-Ingram Cancer CenterChronic Myeloproliferative Neoplasms | Vanderbilt-Ingram Cancer Center
AnatomyDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsInformation ScienceHealth Care
Neoplasm StagingPancreatic NeoplasmsNeoplasmsEndosonographyLymphatic MetastasisSkin NeoplasmsNeoplasms, Cystic, Mucinous, and SerousTomography, X-Ray ComputedPrognosisLung NeoplasmsFluorodeoxyglucose F18Positron-Emission TomographyNeoplasms, Multiple PrimaryRadiopharmaceuticalsLiver NeoplasmsKidney NeoplasmsRetrospective StudiesLymph NodesSensitivity and SpecificityNeoplasm InvasivenessThyroid NeoplasmsNeoplasms, Second PrimaryAdenocarcinoma, MucinousAdenocarcinomaMediastinumMediastinoscopyStomach NeoplasmsGastrointestinal NeoplasmsLymphomaImmunohistochemistryTumor Markers, BiologicalParotid NeoplasmsOvarian NeoplasmsColorectal NeoplasmsDNA, NeoplasmNeoplasm MetastasisNeoplasm Recurrence, LocalRectal NeoplasmsMyeloproliferative DisordersMediastinal NeoplasmsBile Duct NeoplasmsBone NeoplasmsPredictive Value of TestsLymph Node ExcisionNose NeoplasmsBiopsy, NeedleSentinel Lymph Node BiopsyCarcinomaSurvival AnalysisCarcinoma, PapillaryEye NeoplasmsEsophageal NeoplasmsCystadenomaNeoplasms, Connective and Soft TissueAbdominal NeoplasmsNeoplasms, Plasma CellCarcinoma, Pancreatic DuctalThymus NeoplasmsMagnetic Resonance ImagingAppendiceal NeoplasmsMultimodal ImagingAdenocarcinoma, PapillarySoft Tissue NeoplasmsNeoplasms, Glandular and EpithelialCystadenoma, MucinousUterine NeoplasmsBreast NeoplasmsBiopsy, Fine-NeedleColonic NeoplasmsTreatment OutcomeBone Marrow NeoplasmsPreoperative CareEndocrine Gland NeoplasmsNeoplasm ProteinsBiopsyIntestinal NeoplasmsNeoplasms, ExperimentalMouth NeoplasmsProspective StudiesNeoplasms, Vascular TissueFollow-Up StudiesAdenomaTomography, Emission-ComputedSalivary Gland NeoplasmsSplenic NeoplasmsNeoplasms, Radiation-InducedHodgkin DiseaseReproducibility of ResultsCarcinoma, Squamous CellAntigens, NeoplasmDuodenal NeoplasmsTesticular NeoplasmsNeoplasms, Muscle TissuePleural NeoplasmsCystadenocarcinoma, MucinousGallbladder NeoplasmsUrinary Bladder NeoplasmsMelanomaHematologic NeoplasmsTongue NeoplasmsNeuroendocrine TumorsNeoplasms, Adnexal and Skin AppendageLaparotomyVascular NeoplasmsCommon Bile Duct NeoplasmsSweat Gland NeoplasmsNeoplasms, Germ Cell and EmbryonalLymphographyPalatal NeoplasmsDigestive System NeoplasmsPeritoneal NeoplasmsNeoplasms, Complex and MixedAxillaPelvic NeoplasmsHead and Neck NeoplasmsMandibular NeoplasmsCystadenocarcinomaMuscle NeoplasmsDiagnostic ImagingCombined Modality TherapyProstatic NeoplasmsThoracic NeoplasmsFalse Negative ReactionsEndometrial NeoplasmsWhole Body ImagingHeart NeoplasmsNeoplasm GradingCystadenoma, SerousMaxillary NeoplasmsPreoperative PeriodDisease ProgressionPancreatectomyDog DiseasesCarcinoma, Non-Small-Cell LungAnal Gland NeoplasmsAdenoma, OxyphilicCerebellar NeoplasmsNeoplasms, Adipose TissueLaparoscopyBronchial NeoplasmsMeningeal NeoplasmsParanasal Sinus NeoplasmsDisease-Free SurvivalTime FactorsKaplan-Meier EstimateAdrenal Cortex NeoplasmsLaryngeal NeoplasmsOrbital NeoplasmsIleal NeoplasmsSarcomaCarcinoma, HepatocellularNasopharyngeal NeoplasmsCarcinoma, Acinar CellSpinal Cord NeoplasmsVaginal NeoplasmsAdrenal Gland NeoplasmsNervous System NeoplasmsPenile NeoplasmsNeoplasm SeedingCohort StudiesGenital Neoplasms, FemaleJanus Kinase 2Neoadjuvant TherapyThymomaLiver Neoplasms, ExperimentalHemangiosarcomaAdenocarcinoma, FollicularLeiomyosarcomaMyelodysplastic-Myeloproliferative DiseasesSpinal NeoplasmsPeripheral Nervous System NeoplasmsCerebral Ventricle NeoplasmsLymphoma, T-CellBronchoscopyCarcinoma, NeuroendocrineNeck DissectionUterine Cervical NeoplasmsCarcinoma, BronchogenicCarcinosarcomaPancreaticoduodenectomyEndoscopic Ultrasound-Guided Fine Needle AspirationRisk FactorsMultivariate AnalysisRNA, NeoplasmLipomaCarcinoma, Renal CellFacial NeoplasmsFalse Positive ReactionsLymphatic DiseasesBone Marrow ExaminationFatal OutcomeGastrectomyNeoplasm TransplantationProportional Hazards ModelsRadiotherapy, AdjuvantNeoplasms by SiteIncidental FindingsCarcinoembryonic AntigenHistiocytic Disorders, MalignantImmunoenzyme TechniquesLymphoma, B-Cell
PrognosisMiddle AgedHumansMultiple MyelomaPlasma cell neoplasmsMetastasisCancerHistologyBenignPancreatic NeoplasmsMortalityIncidence of malignantEpithelialEpidemiologySurvivalMagnetic ResonanTumor StagingMalignant neoplasmsSpecificityThymicSurgicalTomographyNENsTumourLaparoscopyMethodsMusculoskeletalSmall bowelGallbladderClinical StagingLymphEndoscopicDetectionSurgeryPancreasAdenocarcinomaAcuteMetastatic diseaseTreatmentPrimaryBiopsy
Prognosis9
Middle Aged1
  • AYA neoplasms also differ from those in middle-aged and elderly people, in whom malignancies of epithelial cell origin or carcinomas of several primary sites account for more than 85% of cancers ( 3 ). (scielo.br)
Humans1
  • Calretinin is considered a specific and reliable marker for differentiation of sex cord-stromal tumors in humans, but its expression is demonstrated in all types of canine testicular neoplasms , including germ cells tumor (seminoma) and sex cord-stromal tumors (Sertoli cell and Leydig cell tumors). (thefreedictionary.com)
Multiple Myeloma5
Plasma cell neoplasms5
Metastasis6
Cancer48
Histology2
Benign3
Pancreatic Neoplasms1
Mortality2
  • It shows a high rate of mortality, as in most cases the patient presents with nonspecific symptoms and already in advanced disease stages 1-3 . (scielo.br)
  • The self-expanding metallic stent (SEMS) can be particularly useful in colon obstruction in a pregnant patient with CRC because it allows solving the acute condition providing time to perform a more accurate staging study and to prepare the patient for surgery, thus reducing both post-surgical morbidity and mortality. (isciii.es)
Incidence of malignant1
Epithelial3
  • Data regarding the prognostic significance of the histopathologic classifications of thymic epithelial neoplasms are contradictory, perhaps reflecting issues in reproducibility. (elsevier.com)
  • A total of 456 patients who underwent surgery for thymic epithelial neoplasm at Mayo Clinic Rochester (1942 to 2008) were staged (modified Masaoka, proposed Moran, proposed IASLC/ITMIG) and independently classified by 3 thoracic pathologists (World Health Organization, proposed Suster & Moran [S&M], and Bernatz). (elsevier.com)
  • The term, thymoma, is customarily used to describe neoplasms that show no overt atypia of the epithelial component. (healthlinkbc.ca)
Epidemiology1
Survival7
Magnetic Resonan1
Tumor Staging2
Malignant neoplasms2
Specificity3
  • To compare sensitivity and specificity of endovaginal versus external-array coil T2-W and T2-W + DWI for detecting and staging small cervical tumours. (nih.gov)
  • The purpose of this study was to develop a simple, accurate urine test based on mRNA markers and simple gene signatures that ( a ) could detect TCC before muscle invasion while maintaining high specificity in patients with hematuria or urinary tract infections and ( b ) identify patients most likely to have grade 3 or stage ≥T1 disease. (aacrjournals.org)
  • The combination of CDC2 and HOXA13 distinguished between grade 1 to 2 TCCs and grade 3 or stage ≥T1 TCCs with ∼80% specificity and sensitivity. (aacrjournals.org)
Thymic1
Surgical4
  • ie, they are confined within a specific anatomic compartment except in very advanced stages or if they are disrupted by a surgical procedure. (healio.com)
  • The guidelines begin with clinical presentation to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, adjuvant treatment, management of recurrent and metastatic disease, and patient surveillance. (jnccn.org)
  • The findings were compared with surgical staging using the TNM classification. (semanticscholar.org)
  • Therefore, we decided to analyze the demographic and clinical-surgical aspects of patients with malignant neoplasm of the gallbladder attended in a university hospital of Belém - PA, in the period from 1999 to 2009. (scielo.br)
Tomography2
NENs1
Tumour3
  • Despite these advances, the outcome is mainly determined by the stage of disease at presentation, making early referral to a tumour unit essential. (scielo.org.za)
  • This study evaluated the clinical stage of osteosarcoma at presentation to our tumour unit. (scielo.org.za)
  • In some cases, the detectable tumour stage does not reflect the true stage, because of the limitations of the techniques available in assessing the extent of the disease, e.g., even in the absence of detectable metastatic disease, all cases of long bone osteosarcoma are assumed to have metastatic spread at first presentation and are treated as having disease at a more advanced stage than clinical staging indicates. (vin.com)
Laparoscopy2
Methods3
  • Eventually, this system was used in developing several methods of staging that are recognized worldwide. (healio.com)
  • Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. (sickkids.ca)
  • METHODS: From January 2004 to January 2008, 338 patients underwent definitive treatment for pathologically confirmed clinical stage I NSCLC with lobar resection (n = 260) or SBRT (n = 78). (biomedsearch.com)
Musculoskeletal2
Small bowel2
Gallbladder1
  • The neoplasm of gallbladder is a relatively rare disease, despite being the most common tumor of the biliary tract and the fifth most frequent of the gastrointestinal tract. (scielo.br)
Clinical Staging2
Lymph2
Endoscopic1
  • Since its inception in 2009, transanal minimally invasive surgery has been used increasingly in the United States and internationally as an alternative to local excision and transanal endoscopic microsurgery for local excision of neoplasms in the distal and mid rectum. (nih.gov)
Detection3
  • This study was performed to investigate whether intravenous administration of Gd-DTPA can improve the accuracy of MR imaging in the detection and staging of bladder neoplasms. (semanticscholar.org)
  • The aim of this study is to employ genomic detection methodologies to measure the relative amount of tumor-derived nucleic acids in the blood of patients diagnosed with an early stage solid tumor who are either commencing, currently undergoing or have completed treatment. (clinicaltrials.gov)
  • Here, we describe the selection and validation of mRNA markers for the detection of TCC that are significantly overexpressed in both early- and late-stage disease, have low expression in blood and inflammatory cells, and are stable in urine. (aacrjournals.org)
Surgery6
Pancreas1
Adenocarcinoma6
Acute3
Metastatic disease1
Treatment1
Primary2
Biopsy2